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ABSTRACT 
 
 
M. MAKA TSULUKIDZE.  Off-pump coronary artery bypass graft vs. on-pump 
coronary artery bypass graft surgery: What matters – procedure volume or 
specificity/specialization?  (Under the direction of DR. JAMES STUDNICKI) 
 
 
 Context: Existing research has associated higher provider volume with a lower rate of 
adverse patient outcomes after coronary artery bypass graft (CABG). However, the 
relationship between surgical procedural volume and specialization and clinical outcomes has 
been understudied. Research Objectives: This research examined the effect of surgical 
procedural volume and specialization on patient outcomes for 119,559 patients undergoing 
CABG in Florida short-term acute hospitals from 2000-2006. Methods: Florida Hospital 
Discharge Data were linked with Practitioner Profile Database available from Florida 
Department of Health by using unique surgeon identifiers. Surgeon on-pump and off-pump 
CABG volume was assessed in quartiles. In-hospital complications were measured by using 
Patient Safety Indicators developed by the Agency for Healthcare Research and Quality 
(AHRQ). Analyses included chi-square, t-test, logistic regression and multilevel regression to 
adjust for nested surgeon and hospital effects. Results: In adjusted analyses stratified by on- 
and off-pump CABG, patients operated by surgeons with lower volume of a specific CABG 
type were more likely to have in-hospital mortality: for off-pump CABG quartile 1 
OR=3.05, 95% CI: 1.68-5.53, quartile 2 OR=1.57, 95% CI: 1.10-2.26 and quartile 3 
OR=1.35, 95% CI: 1.01-1.81, and for on-pump CABG quartile 2 OR=1.82, 95% CI: 
1.34-2.47 and quartile 3 OR=1.51, 95% CI: 1.21-1.90. Surgeries performed by physicians 
in lower on-pump CABG quartiles were also significantly associated with increased odds 
of complications (quartile 1 OR=1.97, 95% CI: 1.19-3.26, quartile 2 OR=1.43, 95% CI: 
1.14-1.80 and quartile 3 OR=1.33, 95% CI: 1.14-1.57).  For off-pump CABG only 
iv 
 
quartile 2 physicians retained significance (OR=1.80, 95% CI: 1.29-2.51) for 
complications. Discussion: The volume/outcome relationship for CABG surgery is 
specific to the type of procedure, but not total (all procedures) volume. This finding may 
suggest the need of specialized and focused training of cardiac surgeons as well as 
development of specific CABG outcome reporting protocols to enable sufficient 
differentiation in outcomes of two different types of CABG.  
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CHAPTER 1: BACKGROUND AND LITERATURE REVIEW 
 
 
Introduction 
Over the last three decades an extensive body of literature has examined the 
relationship between provider (hospital and surgeon) volume with the outcomes of 
complex surgical procedures including Coronary Artery Bypass Graft surgery (CABG). 
The vast majority of these studies have documented that higher volume is associated with 
better outcomes and there are no studies suggesting the relationship in the opposite 
direction.
2
 Very few studies have examined the relationship between the volume of a 
specific type of CABG as determined by the use of cardiopulmonary bypass (on-pump 
vs. off-pump CABG). Considerable debate involving these two types of CABG mainly 
evolves around their efficacy, cost-effectiveness, graft patency and other clinical 
outcomes.
3-12
  
CABG is an exception among complex surgical procedures due to its frequency of 
performance. Yet, volume-based policies have often targeted CABG for regionalization 
to further concentrate the surgeries in high-volume centers and by doing so improve 
patient outcomes. However, mixed results of studies examining this volume-based policy 
option have precluded any consensus. For example, based on the body of evidence Dr. 
Shahian
13
 in his editorial argued that the  absolute mortality spread for CABG surgery 
between high- and low-volume centers is small (approximately 1%-2%, compared with 
2 
10%-15% for esophagectomy and pancreatectomy), and that many lower-volume 
programs that outperform state and national averages. 
Perhaps more important in this debate is a recognition of the inadequacy of 
provider volume as a measure of quality of care. While easily accessible and affordable, 
this indicator does not provide any information on fundamental factors underlying 
differences in patient outcomes - selection of patients, preoperative preparation, 
anesthesia, the composition of the surgical team, the techniques used, surgical judgment 
and skill, and postoperative care.
14
 The present study addressed the gap by examining 
some of these factors including patient characteristics, specific CABG techniques used 
(on-pump and/or off-pump), surgical skill and specialization and hospital characteristics.  
Cardiovascular Disease in the United States 
Cardiovascular disease (CVD) death rates declined nationwide during 1995 and 
2005. However, it still accounts for 26% of U.S. annual  mortality.
15
 Nearly 80 million 
American adults, or one in three people, have at least one form of cardiovascular 
disease.
16
  
Coronary artery disease (CAD), also known as coronary heart disease (CHD), is 
responsible for more than half of all CVD-related deaths and represents the most 
common type of heart disease in the US. It affects about 17 million adults aged 20 years 
and older and kills more than 445,000 Americans a year.
17
 Up to 610,000 new cases of 
heart attack and 325,000 recurrent heart attacks occur in the United States yearly.
18
 
As the leading cause of death in the United States, CVD imposes an enormous 
economic burden on the nation.
15
 The estimated total burden of absenteeism, 
presenteeism (a situation where workers remain on the job but have reduced productivity 
3 
due to illness, stress, or other types of distraction), caregiver burden, and premature 
mortality attributable to heart disease ranges up to $122 billion anually.
15
  
Coronary Artery Bypass Graft Surgery (CABG) Procedures in the United States: 
Description of the Procedure and Trends 
Description of the Procedure 
CABG has been widely introduced as a standard of care for patients with coronary 
artery disease.
19
 This highly complex revascularization procedure and advances in 
coronary surgery (e.g., innovations in surgical technique, anesthesia, quality 
improvement initiatives, enhanced myocardial preservation, use of arterial conduits, and 
improved perioperative and postoperative care) have reduced morbidity, mortality, and 
rates of graft occlusion.
20  More than 600,000 patients undergo coronary artery bypass 
graft (CABG) procedures annually in the United States.
19
 
The first coronary artery bypass graft was performed on the beating heart in 
humans in the 1960s.
5
  However, after the advent of the heart-lung machine or 
cardiopulmonary bypass (CPB), off-pump bypass grafting (OPCABG) operations were 
virtually abandoned to be replaced by what we now refer to as conventional coronary 
artery bypass graft (CCABG).
5
  OPCABG was reintroduced in the 1980s, with reclaimed 
popularity achieved by the 1990s.  Recent technical improvements have made OPCABG 
grafting operations a routine procedure with roughly 20% to 25% of CABG procedures 
performed off-pump in the United States currently.
21
  
Conventional Coronary Artery Bypass Graft Surgery (CCABG): CPB has been 
acknowledged to allow the establishment of CABG as a safe and highly effective 
treatment for CAD. It provides an artificial circulation during the procedure, so that 
4 
surgery can be performed while the heart is stopped (cardioplegic arrest). This provides a 
motionless and bloodless operating field for a surgeon, while largely protecting the heart 
from the effects of ischemia.
21
 However, many studies have suggested that CBP may be 
responsible for CABG related complications and mortality.
4, 9, 10
 
Some of the most serious clinical concerns related CPB are: (1) postperfusion 
syndrome caused by contact of blood components with the artificial surfaces of the 
bypass circuit, aortic cross-clamping, and reperfusion injury;
5
 (2) neurologic and 
neuropsychologic complications which can increase, on average 5 to 10 times, the in-
hospital charge for rehabilitation and outpatient support;
5
 (3) higher incidence of 
postoperative chest infection;
5
 (4) intra- and postoperative blood loss, blood product 
utilization and total surgical time.
22
  
Off-pump  Coronary Artery Bypass Graft Surgery (OPCABG): OPCABG has 
been suggested to be a technique with the potential of reducing overall operative 
mortality and morbidity. It is thought to be a particularly valuable technique to benefit 
patients at high risk for pump-related complications.
23
  It is suggested that OPCABG 
provides better myocardial protection, lower perioperative and postoperative 
complication rates, mortality and  morbidity, reduced blood loss and transfusion 
requirements, and alleviate neurological deficits caused through hypoperfusion during 
CPB and embolic events from the CPB pump and cross-clamping of the aorta.
6
 
Conducting the surgery on the beating heart also offers the possibility to maintain the 
functional integrity of major organ systems and reduce mortality and morbidity rates.
5
 
As a result, patients undergoing OPCABG have experienced reduced lengths of 
hospital stay, and reduced costs.
24
 However, definitive data establishing the superiority of 
5 
off-pump CABG over on-pump CABG are lacking and conflicting information regarding 
efficacy of off-pump CABG from prior studies has led to inconsistent adoption of off-
pump CABG as an alternative to on-pump CABG in the United States.
23
 
A meta-analysis performed by Reston et al shows that rates of perioperative 
myocardial infarction, stroke, reoperation for bleeding, renal failure, and mortality were 
lower after OPCABG than after CABG.
25
 Reductions in length of hospital stay, atrial 
fibrillation, and wound infection were also associated with OPCABG. Thus, the study 
concludes that off-pump coronary artery bypass grafting appears to reduce length of 
hospital stay, operative morbidity, and operative mortality relative to on-pump CABG 
while a trend was noticed toward lower reintervention rates with CCABG. 
CABG trends 
CABG is a unique procedure among high-complexity surgeries with regard to its 
frequency – it is 10 times as common as abdominal aortic aneurysm resection in the 
United States, 150 times as common as esophagectomy, and 2.5 times as common as 
carotid endarterectomy.
13
  
However, time trends of CABG procedures show interesting patterns. Over the 
last decade there was a substantial decrease in CABG rates with approximately one-third 
fewer CABG surgeries being performed in 2008 compared with 2001.
26
 Specifically, the 
annual CABG surgery rate decreased steadily from 1742 (95% CI, 1663-1825) CABG 
surgeries per million adults per year in 2001-2002 to 1081 (95% CI, 1032-1133) surgeries 
per million adults per year in 2007-2008 (P<.001) according to a recent study published 
in the Journal of the American Medical Association (JAMA).
26
 Subsequently, the median 
6 
CABG surgery caseload per hospital decreased by 28% (median [interquartile range], 253 
[161-458] in 2001 compared to 183 [98-292] in 2008; P<.001).
26
  
At the same time, many studies have showed that the number of hospitals 
performing CABG procedure increased steadily.
26, 27
 The number of hospitals in the 
Nationwide Inpatient Sample providing CABG surgery increased by 12 percent between 
2001 and 2008.
26
  
Interestingly, while decrease in CABG rate was dramatic, the fall in the total rate 
of coronary revascularization procedures in the US between 2001 and 2008 was 
modest.
26
 This trend arguably reflects a sizeable shift from complex surgical procedures 
towards percutaneous, catheter-based interventions and subsequently the changes in the 
cardiovascular clinical practice patterns.
26
  
Factors influencing the CABG outcomes 
CABG studies identify several major factors as indicators for quality of care and 
contributors to surgical outcomes. These factors can be categorized into three groups: 1) 
provider (hospital, surgeon) volume, 2) provider (hospital, surgeon) specialization, and 3) 
‗organizational skills‘, i.e. hospital characteristics. All these factors are described in detail 
below.   
Provider Volume 
During early 1980s Luft and Flood pioneered research on volume-outcome 
relationship in their seminal studies.
28-30
 Examining 12 surgical procedures including 
CABG Luft demonstrated the positive association between provider volume and surgical 
outcomes and explored potential causal factors underlying the volume-outcome 
relationship. As a result, he postulated a hypothesis that this relationship could be due to 
7 
experience described as ―practice makes perfect ― suggesting that physicians and 
hospitals develop more effective skills with increased volume of patients and/or selective 
referral suggesting that physicians and hospitals with demonstrated superior outcomes 
receive more referrals and thus accrue larger volumes.
2
 The study by Luft et al sugested 
that at least part of the volume-outcome relationship was explaiend by physician referral 
or patient self-referral.
31
  
Since 1980s an extensive body of literature has evolved on the relationship 
between volume and outcome. Almost 5,000 articles, many of which have been published 
in top journals including Journal of the American Medical Association (JAMA), New 
England Journal of Medicine (NEJM), Medical Care, Archives of Internal Medicine have 
examined the relationship for specific procedures and populations including cancer, 
transplant, intensive care, trauma, acute myocardial infarction, carotid endarterectomies, 
abdominal aortic aneurysms, CABG, percutaneous transluminal coronary angioplasty 
(PTCA), etc.
32
 
Two comprehensive reviews of literature on the volume-outcome relationship 
included CABG as one of the frequently performed complex procedures. Halm et al 
reviewed 88 studies covering literature from 1980 to 1999 and examining the volume-
outcome relationship for eight procedures including CABG.
2
 Although the authors noted 
that the methodological rigor of many studies included in the review was modest, all 
studies considered to be of the highest quality found statistically significant relationships 
between volume and outcome. Of all studies reviewed, 77% found statistically significant 
relationships, and no study found a significant relationship in the opposite direction. 
8 
Another review of the volume-outcome literature published in JAMA in 2000 
included 72 articles addressing 40 procedures and diagnoses, including CABG.
33
 For 
CABG Dudley et al reviewed eleven studies, nine of which demonstrated a statistically 
significant differences in mortality between high and low volume centers, and two 
showing a trend.
34
  
Definition of Volume 
Volume is unanimously considered as a proxy measure of quality of care and its 
inadequacy is widely recognized by many studies. Some studies have also argued that 
volume is a weak predictor of outcomes.
23, 35, 36
 However, mostly due to lack of 
information on the fundamental factors and specific processes of care determining the 
volume – outcome effects it remains to be one of the quality measures largely used by 
researchers, policy analysts and policy makers.  
The Agency for Healthcare Research and Quality (AHRQ) has included the 
hospital volume of several surgical procedures in their Inpatient Quality Indicators. These 
quality indicators have subsequently been used by health insurers (e.g., Blue Cross Blue 
Shield in New York State) and state health organizations (e.g., Texas Inpatient Hospital 
Association) for public reporting of volume.
37
 
The Leapfrog Group, a consortium of more than 100 large employers, purchasing 
coalitions, and states that collectively provide health insurance to more than 33 million 
people, recommends health care purchasers consider hospital volume when contracting 
for CABG.
36, 38
 The group has set CABG volume threshold at 500 per year and estimated 
that 1486 deaths may be averted by referring CABG patients to hospitals that perform 
≥500 procedures annually.
38
 
9 
However, despite the attention and consideration given to provider volume as a 
measure of quality of care, important methodological challenges remain with regard to 
clear definition of what constitutes high volume; there is a wide variation in the definition 
of low vs. high volume.
2
 In their systematic review of literature on volume-outcome 
relationship Halm et al noted that ―for almost every condition or procedure for which at 
least three studies were identified, the thresholds used to define high and low volume 
overlapped substantially, that is, the definition of high volume in one study was the 
number used to indicate low volume in another‖.
2
 
Recent studies have also questioned the justification of the 500 annual volume 
threshold for hospitals. Rathore et al conducted a retrospective analysis of the National 
Inpatient Sample database for patients who underwent CABG in 1998–2000.
36
 The study 
intended to evaluate whether Leapfrog‘s standard of ≥500 annual CABG procedures and 
its suggested association with the reduced mortality applies to current practice. A national 
cohort of patients were categorized into three groups: those who underwent CABG at low 
(12-249 cases/year), medium (250-499 cases/year), and high (>or=500 cases/year) CABG 
volume hospitals. The study found that in adjusted analyses patients at low-volume 
hospitals remained at increased risk of mortality compared with patients at high-volume 
hospitals (odds ratio 1.26, 95% CI 1.15-1.39). The mortality risk for patients at medium-
volume hospitals was of borderline significance (odds ratio 1.11, 95% CI 1.01-1.21). 
However, the authors noted that 85% of low-volume and 89% of medium-volume 
hospital-years had risk-standardized mortality rates that were statistically lower or 
comparable to those expected. In contrast, only 6% of high-volume hospital-years had 
outcomes that were statistically better than expected. Basing their judgment on the small 
10 
size of the volume-associated mortality difference and the heterogeneity in outcomes 
within all CABG volume groups. Rathore et al suggested that individual hospital CABG 
volume is not a reliable marker of hospital CABG quality.
36
  
Other studies also suggest that the most important threshold may occur at a lower 
volume than Leapfrog‘s standard and that future studies are needed for the identification 
of optimal volume.
35, 39-41
   
Hospital volume 
A large body of research has found that patients who undergo CABG at higher-
volume hospitals have better outcomes than patients treated at lower-volume hospitals.
42-
49
 Using Medicare data, Birkmeyer et al showed that the overall mortality after CABG 
was 40% higher for hospitals in the lowest volume quintile compared with hospitals in 
the highest quintile.
42
 Hannan et al used data for 12 448 patients undergoing CABG 
surgery in New York State in 1989 and found that there was a significant inverse 
relationship between CABG procedural volume and risk-adjusted mortality for both 
surgeons and hospitals.
44
  
In this light, recent trends in increased number of hospitals providing CABG 
surgeries raise concerns among some researchers. Epstein et al. found that the number of 
CABG surgery hospitals providing fewer than 100 CABG surgeries per year increased 
from 23 (11%) in 2001 to 62 (26%) in 2008 (P<.001). Another study examining the U.S. 
trends in CABG hospital volume and the effect of adding cardiac surgery programs 
speculates that the increasing proportion of CABG procedures performed at low-volume 
hospitals and the declining proportion in high-volume hospitals might increase 
mortality.
50
  
11 
Surgeon volume 
Considerable body of research has explored the associations between surgeon 
volume (the number of procedures performed by the surgeon) and mortality for some 
procedures.
51-54
 However, only few studies examine hospital and physician volume 
simultaneously
2
 and relatively few studies account for hospital volume and other 
potential confounding characteristics of the hospital.
54
  
Using Medicare claims data for 1998-1999 and adjusting for patient and provider 
characteristics Birkmeyer et al
54
 found that surgeon volume was inversely related to 
operative mortality for all eight procedures considered (P=0.003 for lung resection, 
P<0.001 for CABG, endarterectomy, aortic-valve replacement, elective repair of an 
abdominal aortic aneurysm, pancreatic resection, esophagectomy, and cystectomy). The 
study suggested that surgeon volume accounted for a large proportion of the apparent 
effect of the hospital volume with a varying degree for each procedure: it accounted for 
100 percent of the effect for aortic-valve replacement, 57 percent for elective repair of an 
abdominal aortic aneurysm, 55 percent for pancreatic resection, 49 percent for coronary-
artery bypass grafting, 46 percent for esophagectomy, 39 percent for cystectomy, and 24 
percent for lung resection. Furthermore, for most procedures, the mortality rate was 
higher among patients of low-volume surgeons compared to those of high-volume 
surgeons, regardless of the surgical volume of the hospital in which they practiced. The 
findings led the authors to suggest that patients can often substantially improve their 
chances of survival, even at high-volume hospitals, by selecting high-volume surgeons. 
In addition, they concluded that for CABG, elective repair of an abdominal aortic 
aneurysm, and esophagectomy high-volume hospitals (volumes ≥ the Leapfrog cutoffs) 
12 
had lower overall operative mortality rates than low-volume hospitals, largely because 
patients at high-volume hospitals were much more likely to be treated by high-volume 
surgeons than by low-volume surgeons.  
In a systematic review by Halm et
2
 al 69% of studies of physician volume 
reported statistically significant associations between higher volume and better outcomes. 
Interestingly, the same study suggested that surgeon volume seemed to be a more 
important determinant of outcomes than hospital volume in the case of CABG.
2
 A study 
conducted in Taiwan suggested that referring physicians are more inclined to direct their 
patients toward surgeons with better patient outcomes, as opposed to those hospitals with 
superior reputations
55
.  
A study by Peterson et al
45
 also finds that surgeon volume is more important than 
hopistal volume. Examining 267089 CABG procedures performed at 439 US sites 
between January 2000 and December 2001 the study found that 82% of STS programs 
performed fewer than 500 CABG procedures per year, with median CABG procedural 
volume of 253 cases. Surprisingly, however, after adjusting for patient risk and clustering 
effects, mortality decreased only by 0.07% with increasing hospital volume for every 
additional 100 cases and volume was a poor discriminator of better or worse outcomes. 
The volume-outcome relationship was not significant for patients younger than 65 years 
or for low-risk patients with expected mortality rates of less than 1.5% and many low-
volume hospitals had better than average risk-adjusted mortality. 
Provider Specialization  
A body of literature has been growing on what exactly is hospital specialization, 
and what implications does it have for quality and efficiency in medicine.
46 
Much like 
13 
volume, unfortunately, there is no easily applicable definition for what constitutes 
hospital specialization.
56
 Despite this hospital specialization seems quite appealing and 
has been advocated by champions drawn from industry and corporate strategy.
20
 Recent 
and on-going proliferation of service lines in hospitals focused on specific conditions, 
procedures, or populations orginized as heart institutes, cancer centers, orthopedic 
hospitals, women's and children's hospitals is reflectve of this trend.
20
  
Yet, compared to hospital volume, which has been widely embraced as a proxy 
measure for hospital quality, hospital specialization, potentially alternative quality 
measure, has recieved little attention.
20
 
Hospital Specialization 
Hospital specialization may be conceptualized as ―the degree to which a given 
hospital focuses its resources on specific diagnoses (e.g., orthopedic diseases) or 
procedures (e.g., CABG) and may be quantified as the proportion of a hospital's total 
admissions falling within a single disease category or undergoing a specific procedure.‖
20
 
Accordingly, hospital cardiac specialization can be defined as the degree to which a 
hospital concentrates its resources in treating patients with cardiovascular diseases and it 
also follows that a hospital may be low-volume but highly specialized if it concentrates 
resources in select areas, in this case cardiovascular diseases.
20
 
Studies on the relationship of hospital specialization and patient outcomes suggest 
a complex picture with mixed findings.
57-59
 Some suggest that hospital specialization may 
be associated with improved patient outcomes while others report little or no association. 
For example, as one study showed lower risk standardized 30-day mortality at cardiac 
specialty hospitals for AMI (15.0% versus 16.2%, P<0.001) and congestive heart failure 
14 
(10.7% versus 11.3%, P<0.001)
59
 another study found that risk and volume-adjusted 
outcomes after PCI and CABG were similar at specialty cardiac hospitals.
57
 However, 
findings regarding the association of hospital specialization and orthopedic surgeries have 
been quite consistent demonstrating improved patient outcomes at orthopedic specialty 
hospitals compared to general hospitals.
60, 61
 One common limitation for all citied studies 
was their focus on physician-owned specialty hospitals, which is considered to be the 
most extreme example of hospital specialization.
20
  
Relatively few studies have examined specialization in the context of acute-care 
hospitals, again with mixed findings. Nallamothu et al
62
 examined  hospital specialization 
with primary PCI and found that greater hospital specialization was associated with 
shorter door-to-balloon times and lower mortality among patients with ST-elevation–
myocardial infarction. However, using the 5% inpatient Medicare sample 2001 to 2003, 
Hwang et al
63
 found no difference in outcomes after CABG surgery for the   CABG-
performing hospitals categorized as least specialized (<40%), moderately specialized 
(40% to 60%), and cardiac specialty hospitals (>60%). 
A study by Girotra et al
20
 using a large sample of 705,084 Medicare patients 
undergoing CABG in 1130 hospitals during 2001 to 2005 showed a modest association 
between increased specialization and improved CABG outcomes (lower mortality or 
length of stay) after adjusting for patient comorbidity and hospital volume. Additional 
sensitivity analysis excluding physician-owned specialty hospitals or using alternative 
study outcomes did not change the study results. However, there are several important 
caveats related to the adjusted analyses and hospital stratification by hospital 
specialization in cardiovascular diseases. The researchers defined hospital specialization 
15 
by stratifying hospitals into 5 quintiles based on their discharges related to major 
diagnostic category: ≤25.8%, 25.8% to 28.6%, 28.6% to 31.1%, 31.1% to 35.4%, and 
≥35.4% in quintiles 1 through 5, respectively. In unadjusted analyses, overall mortality 
was similar across quintiles 1 to 4 (4.7% to 4.9%), with a modest but significantly lower 
overall 30-day mortality in quintile 5, i.e. hospitals with greater specialization. This 
difference remained the same after accounting for patient characteristics. However, the 
result was no longer significant after adjustment for both patient characteristics and 
hospital volume.  
First important limitation with the quintile method of defining hospital cardiac 
specialization was a lack of variability between quintiles 2 through 4, with mean degrees 
of specialization varying by <6%, which is likely to be masking differences in outcomes 
due to a small percentage.
56
  Secondly, the authors have noted themselves that because 
volume is endogenous to specialization to some extent, they were unable to fully 
disentangle its effect from the relationship between specialization and outcomes. This 
seems to be a critically important consideration as it may suggest biasing the results 
towards the null due to over adjustment bias.   
Surgeon Specialization 
One of the main aspects characterizing a physician‘s specialization is specialty 
board certification, on which information is publicly available and easily accessible. 
Specialty board certification is, however, voluntary and does not appear to provide 
physicians with additional legal privileges in the practice of medicine.
64
 
The American Board of Medical Specialties (ABMS) is the umbrella organization 
for 24 approved medical specialty boards.
65
 Six out of these 24 boards are purely surgical 
16 
(Colon and Rectal Surgery, Neurological Surgery, Orthopaedic Surgery, Plastic Surgery, 
General Surgery, Thoracic Surgery) while other four implicitly include surgical sub-
specialization (Obstetrics and Gynecology, Ophthalmology, Otolaryngology, Urology). 
Dr. Richard Corlin, president-elect of the American Medical Association, has been cited 
to emphasize that ―[thoracic] board certification is not legally required to practice . . . but 
it is considered a general mark of a physician‘s preparation, learning, knowledge and 
experience.‖
66
 The certification process, then, reflects the level of knowledge and 
practical skills held by surgeons.
66
 In 2002, more than 85% of licensed thoracic 
physicians held a valid certificate.
65
 
A number of studies have supported the validity of board certification as an 
indicator of specialization and superior performance. Successfully passing board 
certification examinations has been positively associated with clinical performance 
ratings,
67, 68
 National Board of Medical Examiners examination scores,
69
 and in-training 
examination scores.
70
 
A systematic review by Sharp et al
71
 examined the link between physician 
certification and clinical outcomes and showed that of the 33 studies, 16 demonstrated a 
significant positive association between certification status and positive clinical 
outcomes, three revealed worse outcomes for certified physicians, and 14 showed no 
association. However, as the researchers note, three negative findings and one finding of 
no association were identified in two papers with insufficient case-mix adjustments in the 
analyses.  
A study examining inpatient complications, mortality, and hospital length of stay 
following colon resection using an Illinois sample found that increasing years following 
17 
board certification was associated with reduced morbidity and mortality after adjusting 
for patient and hospital characteristics.
72
 In a review of the effect of surgeon experience 
and specialization on cancer surgery outcomes, Bilimoria et al
73
 found that specialized 
surgeons had better outcomes and that time since American Board of Surgery (ABS) 
certification was a significant predictor of patient outcomes. 
Another study investigating the association between board certification and 
physicians‘ demographics and their performances during medical school and residency 
demonstrated an overall positive relationship between physicians' board certification 
status and their academic performances.
74
 
A recent article published in JAMA ‗the Role of Physician Specialty Board 
Certification Status in the Quality Movement‖ offers an interesting insight regarding the 
subject.
75
 The authors argue that certification has received minimal, and therefore 
inadequate notice within the new quality movement. Specifically, they point out to the 
lack of attention to renewing or maintaining certification largely overlooked by policy 
regulators, health plans, and others involved in the quality movement. The study 
concludes that a physician's current certification status should be among the evidence-
based measures used within the context of health care quality movement.  
A different approach to account for physician specialization has been offered by a 
recent study published in the Archives of Surgery.
76
 Examining career phase, overall 
surgical workload and specialization of board-certified general surgeons the study found 
that the workload composition (i.e. number of specific surgeries characterized based on 
CCS) changed as general surgeons‘ career advanced from early (<10 years since board 
certification) to early mid (10-19 years since board certification), late mid (20-29 years 
18 
since board certification) or late (≥30 years since board certification) career phase. 
Specifically, the percent of cardiovascular surgeries among late career surgeons was 
higher, and the percent of digestive surgeries lower, than for any of the three other career 
phase cohorts. Subsequently, this variation in surgical composition, which can also be 
described as a narrow specialization within the practice of general surgery, has affected 
the surgical outcomes in several important ways. Compared to late career surgeons, the 
rate of complications from cardiovascular surgeries was higher for surgeons in early 
career phase (Rate Ratio, RR 1.23, 95% Confidence Interval, CI 1.06 – 1.44) and late 
mid-career phase (RR 1.18, CI 1.02 – 1.37). The mortality rate for cardiovascular 
procedures was also higher for early career surgeons (RR 1.23, CI 1.04 – 1.46). For 
digestive surgeries, early career surgeons had lower complication rates than late career 
surgeons (RR 0.86, CI 0.75 – 0.99).  
A systematic review by Chowdhury et al
77
 included 163 studies examining 42 
different surgical procedures and covering 13 surgical specialties. Twenty two studies 
reported surgeon specialization and  in 91 per cent of studies specialist surgeons had 
significantly better outcomes than general surgeons. The review also noted a varying 
magnitude of the benefit of high surgeon volume and specialization across the specialties. 
The study concluded that high surgeon volume and specialization are independently 
positively associated with patient outcomes. Interestingly, the study also noted that high 
hospital volume is of limited benefit.  
Organizational/Hospital Factors 
Organizational/hospital factors that may influence the patient outcomes are 
largely understudied. As Elizabeth Moxey and David B. Nash
32
 note in their summary of 
19 
the literature on volume-outcome in CABG and PTCA more than 30 years after Luft and 
Flood authored seminal studies on volume-outcome research ―many of the questions 
posed by Luft and Flood remain unanswered: [..] How do other members of the team 
(nursing staff, anesthesiologist, OR staff, etc.) influence the relationship? Do high 
volume hospitals have standards and protocols that account for their better performance?‖ 
In a systematic review of the volume-outcome literature, intended to support a 
May 2000 Institute of Medicine workshop, Halm et al
2
 provided a clear conceptual model 
outlining  potential explanatory factors underlying the volume-outcome relationship, 
which later was included in the Committee on Quality of Health Care in America and the 
National Cancer Policy Board Workshop Summary
78
 (Figure 1). This model along with 
patient and physician characteristics identifies hospital or organizational ―skills‖ as one 
of the important contributors to patient outcomes.  
A number of studies have speculated that high volume hospitals may enhance the 
performance of low-volume physicians.
13
 The explanation most frequently offered by the 
studies showing this important synergy between the two provider levels is the processes 
of care,
13, 78
specialized and more differentiated departments and subunits as well as  more 
specialized staff.
30
 In addition, studies have found that many low-volume centers have 
excellent outcomes,
79
 which again calls for further investigation and careful scrutiny of 
underlying mechanisms (processes of care, specific standards and protocols, etc) for high 
performance. Another important question, also raised by many investigators, relates to 
the relative contribution of other members of the team (nursing staff, anesthesiologist, 
OR staff, etc.) – do they influence the volume-outcome  relationship?
32
 
20 
The role of anesthesiologist deserves special attention particularly for performing 
OPCABG surgeries. The beating-heart surgery is incredibly challenging for 
anesthesiologists as they need to address several major factors that influence the surgical 
outcomes. Namely, during the surgery anesthesiologist has to ensure the maintenance of 
hemodynamic stability during heart enucleation necessary for accessing each coronary 
artery, and the management of intraoperative myocardial ischaemia as coronary flow is 
interrupted during grafting.
24, 80
  
Equally important factors may include nursing staff who are more familiar with 
certain types of procedures and therefore may attain and maintain more proficiency in 
their performance. In addition, it is also conceivable that higer volume and/or more 
specilized hopistals may purchase specialized equipment for specific surgeries.  
Although the body of literature on volume-outcome relationship is extensive, the 
research examining all these or some of these organizational factors and hospital ‗skills‘ 
is very limited. A study by Brown et al
24
 examined surgical performance of the operating 
team performing off-pump CABG procedures. The underlying premise was that with the 
increasing experience of the cardiovascular surgical team performing off-pump CABG 
procedures clinical decision-making processes and technical skills necessary for treating 
all CABG patients would improve (regardless of whether or not cardiopulmonary bypass 
is used). The study found that although high-volume OPCABG facilities achieved better 
outcomes, mortality rates were only marginally lower compared to low-volume 
OPCABG facilities and the difference was not statistically significant. However, higher 
volumes of OPCABG were associated with lower patient and facility complication rates 
for major outcomes (shock/hemorrhage, neurologic, renal, and cardiac) with statistically 
21 
significant results for all four complications. Similarly, six out of seven minor 
complication rates were lower for high-volume OPCABG facilities.  
Summary 
Two seminal reports of the Institute of Medicine (IOM)
81, 82
 documented that U.S. 
health system performs far below obtainable levels of patient safety
83
 and estimated that 
44,000 to 98,000 Americans die each year as a result of medical errors. Thus, the call for 
achieving excellence in quality and quality improvement remains open. 
It is within this context that the effect of hospital and surgeon volume and 
provider specialization has received special attention.  These major structural 
characteristics are largely used in health services research and policy analysis to inform 
quality improvement initiatives. However, even with the extensive body of evidence on 
the positive association of volume with improved outcomes the underpinnings of the 
volume-outcome relationship remain poorly understood, and the policy implications of 
this relationship are widely disputed and unclear.
32
  
It is important to seek the answers to the question related to this important debate: 
precisely what is the advantage of higher-volume providers - doing things more often or 
doing things differently. Some studies have attempted to investigate whether surgical 
procedures performed in high volumes or using similar technique (e.g. on-pump vs. off-
pump CABG) make the difference.  
To date, there is a paucity of literature examining the relationship between 
procedure volumes and underlying mechanisms accounting for differences in off-pump 
and on-pump CABG operation outcomes. 
22 
A study by Konety et al
23
 showed that the proportion of CABG procedures 
performed off-pump may be more important than the actual volume of off-pump CABG 
operations performed at a hospital. The authors speculated that some hospitals that may 
‗‗specialize‘‘ in off-pump procedures attain certain level of surgical skill, and therefore 
achieve better outcomes. However, Konety and colleagues did not account for physician 
volume or technical expertise, an important factor which is likely to be related to the 
procedural outcomes and is the main focus of the present study.   
Another study, conducted by Brown et al,
24
 also analyzed the patient and hospital 
characteristics at high- and low-volume OPCABG sites to examine their association with 
clinical outcomes. However, selecting the operating team performing OPCABG 
procedures as the unit of analysis, the study did not account for individual surgeon 
experience and technical skills.  
Few dispute that the individual surgeon‘s knowledge and practical abilities play a 
critical role in the practice of surgery. However, this also is the area of health services 
research that remains largely understudied and unaddressed. Discussing the role of the 
individual physicians, their skills and expertise in the overall quality framework Brennan 
et al
75
 suggested that ―the minimal attention to the role of the individual physician is a 
missed opportunity‖ for achieving better quality of care.  
The present study addresses the existing knowledge gap by examining surgeon 
characteristics, their caseload, and their experience, and the association between those 
measures and patient outcomes after two different types of CABG with or without 
cardiopulmonary bypass. Surgeon volume has been suggested by previous studies to be a 
more important determinant of outcomes than hospital volume in the case of CABG.
2
 The 
23 
addition of surgeon experience and characteristics to the analysis will offer an important 
insight in the volume-outcome relationship for CABG surgeries.  
This study also examines the role of organizational characteristics such as hospital 
ownership and size, teaching status, overall procedural volume and CABG volume. 
Previous studies have suggested that high volume hospitals may actually enhance the 
performance of low-volume physicians.
79
 In addition, it could be argued that large 
hospitals with high overall volumes have specialized facilities and staff, which in turn 
provides for good teamwork, effective pre- and postoperative care and better 
management of other processes of care.  This focused and specialized management of 
patients across the continuum of care may be better characterized as economies of scale 
rather than ―practice makes perfect,‖ as suggested by Luft et al.
31
 
The current study contributes to better understanding of the volume-outcome 
relationship.  It may inform policy decisions in several important ways. If findings of the 
study suggest that performance of a specific type of CABG (CCABGG vs. OPCABG) is 
associated with better outcomes, specialized and focused training of cardiac surgeons 
may be warranted. Although mandatory CABG Outcomes Reporting Program has been 
widely implemented (Appendix A) there is no differentiation in public reporting of two 
specific types of CABG. If surgeons and hospitals have different patient outcomes 
depending on a type of CABG performed the reporting protocols should be altered 
accordingly, as providers performing well for on-pump CABG may not necessarily be the 
same as those that perform well for off-pump CABG.
23
 
Finally, future directions for CABG research should be focused on collecting 
richer data with more clinical detail to address the concerns about important contributing 
24 
factors for improved patient outcomes. At the same time, efforts should be made to 
develop a provider ‗rating‘ format that does not rely solely on volume thresholds and can 
be used for objectively evaluating surgical outcomes based on better measures of quality 
of care that can be publicly available.   
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CHAPTER 2: OBJECTIVES, HYPOTHESES AND THEORETICAL FRAMEWORK 
 
Main objective of this study is to examine the role of proportional and cumulative 
surgical volume for two specific types of CABG as well as the contribution of surgical 
skills and specialization and hospital organizational factors to the patent outcomes after 
CABG surgery.  
The specific objectives and hypotheses are described below. 
Objective 1:  to explore the relationship between specific CABG procedures, 
specialty training and selected outcomes 
H1.1:  Higher volume of a given specific type of CABG (OPCABG and/or 
CCABG) and specialized surgical training (thoracic surgery vs. general surgery) will lead 
to better outcomes, measured by the occurrence of in-hospital complications or in-
hospital mortality.  
H1.2:  The lowest volume of CABG procedures will lead to markedly worse 
outcomes (in-hospital complications and mortality) compared to other volume categories.  
H1.3: Cumulative surgical volume will be significant perdictor of improved 
outcomes (in-hospital complications and mortality).   
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TABLE 2.1: Variables and Data Sources for Analysis, Objective 1, H1.1 through 
H1.3 
Variable Data Sources 
OPCABG volume per surgeon  Number of off-pump CABG procedures, 
2000-2006 Florida Hospital Inpatient 
Discharge Data 
 
CCABG volume per surgeon Number of on-pump CABG procedures, 
2000-2006 Florida Hospital Inpatient 
Discharge Data 
 
Total CABG volume  Number of total CABG procedures, 
2000-2006 Florida Hospital Inpatient 
Discharge Data 
 
General Surgery  Board Certification   Florida Practitioner Profile Data File  
 
Thoracic Surgery Board Certification   Florida Practitioner Profile Data File 
 
≤ 88 CABG surgeries per seven year 
study-period 
Number of any type of CABG procedures 
per 7-year, 2000-2006 Florida Hospital 
Inpatient Discharge Data 
 
Cumulative surgical volume Number of total CABG procedures 
(CCABG, OPCABG or both) over 
7years, 2000-2006 Florida Hospital 
Inpatient Discharge Data 
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Objective 2: to examine the relative contribution of hospital characteristics to the 
selected outcomes  
H2.1: Low-volume CABG providers in high-volume hospitals (CABG volume and 
total discharges) will have better outcomes compared to low-volume CABG providers in 
low-volume hospitals.  
H2.2: Hospitals with larger size, more total discharges, and teaching status will 
have better outcomes for in-hospital complications and in-hospital mortality.  
 
 
TABLE 2.2: Variables and Data Sources for Analysis, Objective 2, H2.1 and H2.2 
Variable Data Sources 
Hospital CABG volume  
 
Number of CABG procedures per 
hospital, 2000-2006 Florida Hospital 
Inpatient Discharge Data 
 
Total discharges Number of total discharges per hospital, 
American Hospital Association Annual 
Survey 
 
Hospital characteristics  
 
Hospital teaching status, ownership, 
American Hospital Association Annual 
Survey 
 
Bed size  Number of beds per hospital, American 
Hospital Association Annual Survey 
 
 
Conceptual Framework  
The IOM volume-outcome relationship model
1
 developed by Halm et al
2
 
referenced in the Background and Literature Review section of this research has served 
as foundation for the conceptual framework for the present study. The framework 
30 
incorporates the following elements: patient characteristics, disease severity/comorbidity, 
processes of care, hospital characteristics, operating team and operating surgeon 
characteristics and surgical technique. The last three elements (operating surgeon, 
operating team and hospital characteristics) have been added to the framework based on 
the research questions of the current study.  
Areas of research that cannot be addressed using the available data are 
highlighted. These areas include clinical characteristics (e.g. ejection fraction, left 
ventricular (LV) function, anatomy of Coronary Artery Disease), processes of care (e.g. 
pharmacologic therapies such as use of heparin, aspirin, or β-blockers, adjunctive 
procedures such as use of intra-aortic balloon pump or stents, appropriateness of patient 
selection and surgical technique) and operating team characteristics (e.g. skills of 
anesthesiologist, clinical perfusionist, nursing staff).  
The interactions and interrelationships between these patient and provider 
characteristics lead to certain outcomes of surgical care, in this case defined as in-hospital 
mortality or in-hospital complications, the latter being measured as the presence of any of 
selected PSIs.  
Figure 2.2  provides a succinct view of the framework and highlights the areas of 
research to be examined by the current study, as well as those that need to be addressed, 
to provide better understanding of the relationship between quality of care and patient 
outcomes.  
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CHAPTER 3: METHODS 
 
 
Study Design, Study Population and Data Sources 
Data Sources 
This pooled cross-sectional study used several sources of retrospective administrative 
data to examine the research questions. 
1. Florida Hospital Inpatient Discharge Data (HIDD) to obtain inpatient discharge 
data 
2. Florida Practitioner Profile Data File (PPDF) to identify board certified thoracic 
and general surgeons 
3. Florida Hospital Characteristics File (HCF) to obtain hospital variables 
A common physician and/or hospital identifiers contained in all data files listed above 
allowed linking the data to incorporate information from the selected data sets and create 
in-depth analysis. Detailed descriptions of the data files are given below. 
Florida Hospital Inpatient Discharge Data (HIDD)  
The Florida hospital inpatient discharge data is obtained from Agency for Health 
Care Administration (AHCA) continuously updated repository of health care data. The 
AHCA collects inpatient discharge data from 269 acute care, short-term psychiatric, 
long-term psychiatric and comprehensive rehabilitation facilities and comprehensive 
rehabilitation hospitals in Florida. The data are updated on a quarterly basis. Each record 
in the dataset corresponds to an individual inpatient hospital stay. The file has patient-
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level data and includes information on patient demographics, diagnosis and procedure 
codes, attending physician, operating or performing physicians, and total gross charges. 
The Health Data Store created a data dictionary for the file (available at 
http://www.healthdatastore.com/ahca-florida-hospital-discharge-data.aspx), which 
describes the data elements and layout. 
The CABG discharges were identified using calendar year 2000 through 2006 
inpatient discharge records. The de-identified inpatient records in the HIDD included up 
to 31 diagnosis and procedure codes, demographic characteristics such as patient age, 
sex, race/ethnicity, zip code, principal payer, admission type and admission source, 
length of hospital stay (LOS), discharge status, unique attending physician, operating 
physician and hospital identifiers, reporting year, reporting quarter, charges by 22 
revenue centers, total gross charges, diagnosis related group (DRG), day of the week 
admitted, days to procedure. The diagnosis and procedure codes in the dataset were based 
on ICD-9-CM coding. 
 
TABLE 3.1: List of variables used in the study, HIDD file   
Variable name Variable description Code/Values 
 
Age  
 
 
Patient‘s age in years at 
admission  
 
Numeric, continuous 
 
Gender             The gender of the 
patient at admission 
Numeric, nominal 
1 Male 
2 Female 
Race             Race of patient 
 
 
Numeric, nominal 
1-American Indian or Alaska Native 
2-Asian or Pacific Islander 
3-Black or African American 
4-White 
5-White Hispanic 
6-Black Hispanic 
7-Other (Use if not described above) 
8-No Response (Patient refuses/fails to disclose) 
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TABLE 3.1 (continued) 
Variable name Variable description Code/Values 
Discharge Status             Patient disposition at 
discharge 
Numeric, nominal   
 
01 – Discharged to home or self-care 
02 – Discharged to a short-term general hospital 
03 – Discharged to a skilled nursing facility 
04 – Discharged to an intermediate care facility 
05 – Discharged to another type of institution 
06 – Discharged to home under care of home 
health care organization 
07 – Left this hospital against medical advice 
(AMA) or discontinued care 
08 – Discharged home under care of home IV 
provider on IV medications (discontinued 2005) 
20 – Expired 
50 – Discharged to hospice – home 
51 – Discharged to hospice – medical facility 
62 – Discharged to an inpatient rehabilitation 
facility including rehabilitation distinct part 
units of 
a hospital 
63 – Discharged to a Medicare certified long 
term care hospital 
65 – Discharged to a psychiatric hospital 
including psychiatric distinct part units of a 
hospital 
 
Pay Source         
 
Principal Payer Code 
 
Character, nominal   
A – Medicare 
B – Medicare HMO or Medicare PPO 
C – Medicaid 
D – Medicaid HMO 
E – Commercial Insurance 
F – Commercial HMO 
G – Commercial PPO 
H – Workers‘ Compensation 
I – CHAMPUS/TriCare 
J – VA 
K – Other State/Local Government 
L – Self Pay/Under-insured 
M – Other 
N – Charity 
O – KidCare 
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TABLE 3.1 (continued) 
Variable name Variable description Code/Values 
Admission Type              Admission Type (A 
code indicating the 
priority of this 
admission) 
 
Numeric, nominal   
 
1- Emergency 
2- Urgent 
3- Elective 
4- Newborn   
5- Trauma Center 
9- Information not Available 
 
Admission Source              
 
 
Source of 
Admission/Point of 
Origin 
 
Numeric, nominal   
 
01 = Physician Referral 
02 = Clinic Referral 
03 = HMO Referral 
04 = Hospital Transfer (different facility) 
05 = Skilled Nursing Home 
06 = Transfer- other Facility 
07 = Emergency Room 
08 = Court/Law Enforcement 
09 = Other 
 
Diagnosis Code  
 
A code representing a 
condition that is related 
to the services provided 
during the 
hospitalization 
excluding external 
cause of injury codes.  
ICD-9-CM or ICD-10-
CM code 
Alphanumeric 
 
Procedure code  
 
 
The ICD-9-CM or ICD-
10-CM code identifying 
all significant 
procedures other than 
the principal procedure. 
Report those that are 
most important for the 
episode of care and 
specifically any 
therapeutic procedures 
closely related to the 
principal diagnosis 
 
 
Alphanumeric 
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TABLE 3.1 (continued) 
Variable name Variable description Code/Values 
Discharge Year            
 
Year of discharge. The 
patient‘s year of 
discharge. For example, 
a patient discharged on 
July 7, 2004 would 
have a discharge year of 
‗2004.‘  
Numeric  
 
 
DRG 
 
Diagnosis Related 
Group 
DRG from federal 
(CMS) Grouper 
 
Numeric 
 
MDC 
 
Major Diagnostic 
Category 
MDC from federal 
(CMS) grouper 
 
Numeric 
 
 
Florida Practitioner Profile Data File (PPDF) 
PPDF was obtained from the Florida Department of Health (DOH) Licensee Data 
Center. The downloadable data files are available at the following website 
https://ww2.doh.state.fl.us/downloadnet/Profile.aspx.  
PPDF included self-reported information from licensed Medical Physicians, 
Osteopathic Physicians, Podiatric Physicians, Chiropractic Physicians, and Advanced 
Registered Nurse Practitioners. The practitioner information contains the following 
characteristics: certification board, specialty certification area, specialty certificate (if 
available), education and training, professional and post graduate training,  academic 
appointments, current practice and mailing addresses, staff privileges, faculty 
appointments and other affiliations, financial responsibility, proceedings and actions 
including legal litigations, board disciplinary action taken against the practitioner.  
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As Florida DOH indicates the practitioner profile summarizes data submitted by 
the practitioner and has not been verified by the Department unless otherwise indicated 
(http://doh.state.fl.us/mqa/Profiling/pp_about.html). 
 
 
TABLE 3.2: List of Variables Used in the Study, PPDF file   
Variable name Variable description 
MD Operating       Operating or performing physician identification 
number. The Florida license number of the medical 
doctor, osteopathic physician, dentist, podiatrist, 
chiropractor, or advanced registered nurse practitioner 
who had primary responsibility for theprocedure  
 
MD Attending          
 
Attending physician identification number. The Florida 
license number of the medical doctor, osteopathic 
physician, dentist, podiatrist, chiropractor or advanced 
registered nurse practitioner who had primary 
responsibility for the patient‘s medical care and 
treatment or who certified as to the medical necessity 
of the services rendered 
 
Specialty Board  Surgeon certifying board  
 
Specialty Certification  Specialty certification name 
 
License ID  System defined numeric used to identify a license 
through the system 
 
License Number  Current license number. Refers primarily to the number 
printed on the wall license. Existing wall license 
numbers are not necessarily unique even within a 
profession, and they are not identical to the identifier 
for most boards. This number will only change if the 
license is revoked and reissued for some reason. For 
duplicate licenses, the number will not change. 
 
Last name of the Licensee Last name of a surgeon  
 
First name of the Licensee First name of a surgeon 
 
Middle Name of the Licensee Middle name of a surgeon  
 
License Status Description  Active/inactive status of the license  
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Florida Hospital Characteristics File (HCF)  
HCF included hospital identifier, institution name, type, address, county, 
ownership  and teaching status, total discharges, and bed size.  
Human Subject Protection  
Although the study uses de-identified data approval of the UNCC Institutional 
Review Board (IRB) has been obtained (Protocol # 10-05-28).  
Study population  
Surgeons with the American Board of Surgery (ABS) certification in General 
Surgery (GS) and American Board of Thoracic Surgery (ABTS) certification in Thoracic 
Surgery (TS) were included in the study. The GS subspecialties of Hand Surgery and 
Pediatric Surgery and TS subspecialty of Congenital Heart Surgery were excluded. The 
surgeons were initially categorized based on their performance of CCABG, OPCABG or 
both types of CABG in the following groups: Group 1- surgeons who performed on-
pump CABG only (n=26), Group 2- surgeons who performed off-pump CABG only 
(n=14), Group 3- surgeons who performed both types of CABG. The third group had two 
subgroups: 3a- surgeons who performed predominantly on-pump CABG (n=190), 3b- 
surgeons who performed predominantly off-pump CABG (n=32). The categorization of 
surgeons in predominantly CCABG or OPCABG subgroups was based on simple 
majority of CABG type performed by these surgeons. Figure 1 shows the surgeon group 
categorization.   
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FIGURE 3.1: Surgical Caseload Groups  
 
As CABG procedure is typically performed by thoracic or general surgeons, this 
study considered only those patients on whom CABG was performed by board certified 
thoracic or general surgeons only. Operating surgeon for CABG procedure was identified 
using the unique physician identification number contained in the ―MD_operating‖ field 
of the HIDD. Previous research has indicated the reliability of this approach in 
identifying operating surgeons.
87, 88
 Next, the unique operating surgeon identifier 
contained in the HIDD file was linked to Florida practitioners profile data to obtain the 
board certification information for each surgeon. A surgeon was determined to be a 
thoracic or general surgeon if the practitioner profile database indicated that he/she was 
certified by the American Board of Thoracic Surgery (ABTS) or American Board of 
Surgery (ABS) or ―thoracic surgery‖ or ―general surgery‖ was identified as a specialty 
program area. When operating physician reported multiple certifications only those 
including thoracic or general surgery certification were retained. Next, certification 
information for 264 surgeons remaining in the study was verified through American 
Board of Medical Specialties ABMS online database for final accuracy and data 
On-Pump CABG 
100%                   
 (n=26) 
Off-Pump CABG 
100%               
 (n=14) 
Mixed Group         
- 
(n=222) 
  
 
Predominantly 
On-Pump CABG 
(n=190)                   
 (n=26) 
Predominantly 
Off-Pump CABG 
(n=32)                   
 (n=26) 
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validation. The ABMS is a not-for-profit organization assisting 24 approved medical 
specialty boards in the development and use of standards for physician evaluation and 
certification (http://www.abms.org/).  
To identify patient-discharges (n= 119,658) undergoing CABG as a principal 
procedure performed by the surgeons included in the study population, ICD-9-CM 
principal procedure codes 36.10–36.19 were used. Although no prior studies have 
examined the reliability of the coding for the use of a pump for CABG surgery in 
administrative data, Konety et al have successfully used the presence of ICD-9-CM 
procedural code for intracorporeal pump (39.61) or cardioplegia (39.63) to distinguish 
between patients undergoing on-pump CABG or off-pump CABG.
23
   
Dependent Variables/Outcome Measures 
Patient Safety Indicators 
Patient Safety Indicators (PSIs) were chosen as an outcome variable to measure 
postoperative in-hospital complications. PSIs were developed by the Agency for 
Healthcare Research and Quality (AHRQ) and revised by the University of California-
Stanford University Evidence-based Practice Center (UCSF-Stanford EPC). The PSIs are 
a set of indicators to provide information on potentially preventable in-hospital 
complications and adverse events. PSI software 
(http://www.qualtiyindicators.ahrq.gov/psidownload.htm) is designed for use with 
administrative data and is commonly being utilized in research. PSIs have been found to 
be reliable measures, with good construct validity and stability over time
89-92
 and have 
been described in detail in numerous articles.
93-96
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PSIs selected for this study from the set of 20 provider level indicators based on 
clinical relevance to CABG surgery included: failure to rescue (PSI 4), foreign body left 
in during procedure (PSI 5), iatrogenic pneumothorax (PSI 6), selected infections due to 
medical care (PSI 7), postoperative hemorrhage or hematoma (PSI 9), postoperative 
physiologic and  metabolic derangements (PSI 10), postoperative respiratory failure (PSI 
11), postoperative pulmonary embolism or deep vein thrombosis (PSI 12), postoperative 
sepsis (PSI 13), accidental puncture and laceration (PSI 15). Patients were identified as 
having a complication if any of the 10 PSIs were present on the discharge record.   
Although concern has been expressed regarding using PSIs without ―present on 
admission‖ (POA) indicator due to limited ability of such approach to distinguish 
between complications and pre-existing comorbid conditions eight PSIs used in the 
current study (PSI 5, PSI 6, PSI 7, PSI 9, PSI 10, PSI 11, PSI 13, and PSI 15) have been 
found to remain potential patient safety problems after eliminating conditions reported as 
POA.
97, 98
 The only patient safety indicator with less likelihood to be still considered a 
potential patient safety problem after eliminating conditions reported as POA was PSI 12, 
postoperative pulmonary embolism or deep vein thrombosis.
97
  
Rationale for selecting the above listed PSIs as the outcome measures is described 
below.  
Failure to rescue (PSI 4)  
The failure-to-rescue indicator is considered to be a clinically meaningful and 
well validated quality measure.
99
 This PSI was originally proposed by Silber et al.
100
 
After conducting extensive empirical analyses on PSI 4the project team developing the 
AHRQ PSI concluded that it generally performs well on several different dimensions, 
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including reliability, bias, relatedness of indicators, and persistence over time.
101
 One 
major advantage emphasized by the AHRQ panelists was that this PSI is fundamentally 
different than other AHRQ PSIs, as it reflects effectiveness in rescuing a patient from a 
complication versus preventing a complication.
101
 
A study using Veteran Affairs (VA) administrative data examining  the construct 
validity of the PSIs found that out of total 11,411 PSI events 46% occurred in surgical 
hospitalisation and 54% in medical hospitalisation.
90
 Failure to rescue had the highest 
rate observed among all AHRQ PSIs,  155.55 per 1000 discharges and was significantly 
associated with the AHRQ PSIs for death in low-mortality DRGs, postoperative 
pulmonary embolism or deep vein thrombosis, and decubitus ulcer.
101
 
Foreign body left in during procedure (PSI 5)  
Surgeons and operating room teams typically rely on the practice of countin 
surgical instruments as a means of eliminating foreign bodies left in during procedure. 
However, practices are not standardised and occurrence of such adverse event may signal 
a serious system failure that should be addressed.
101
 Thus, foreign body left during 
procedure is a suitable measure of patient safety. 
Iatrogenic pneumothorax (PSI 6) 
Iatrogenic pneumothorax may occur following intrathoracic surgery or during any 
procedure which involves entry into the pleural cavity, such as thoracentesis or placement 
of a chest drain. The leading causes of iatrogenic pneumothorax were transthoracic 
needle aspiration (128), subclavicular needle stick (119), thoracentesis (106), 
transbronchial biopsy (54), pleural biopsy (45) and positive pressure ventilation (38).
102
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Study by Çelik et al
103
showed that 56.7 % of the invasive procedures, which 
caused iatrogenic pneumothorax, were performed under emergency conditions and 43.3 
% were performed under elective conditions. In 69 patients (42 %) the procedures were 
performed due to underlying lung diseases and in 95 patients (58 %) for diseases other 
than lung diseases. The most frequent procedure type causing iatrogenic pneumothorax 
was central venous catheterization, with 72 patients (43.8%). The other frequent causes 
were thoracentesis with 33 patients (20.1%) and barotrauma due to mechanical 
ventilation with 15 patients (9.1%).
103
 
While being frequent in occurrence iatrogenic pneumothorax also is a preventable 
complication. Thus, it is a suitable measure of patient safety. 
Selected infections due to medical care (PSI 7)  
This PSI is intended to flag cases of infection due to medical care, primarily those 
related to intravenous (IV) lines and catheters. This PSI is defined on a provider level by 
including cases based on secondary diagnosis associated with the same hospitalisation. 
Patients with potential immuno-compromised states (e.g., AIDS, cancer, and transplant) 
are excluded, as they may be more susceptible to such infections.
101
  
Postoperative hemorrhage or hematoma (PSI 9)  
Postoperative haemorrhage or haematoma is a harmful and potentially life-
threatening complication in surgical care. Thus, it is a suitable measure of patient 
safety.
101
 
Postoperative physiologic and metabolic derangements (PSI 10)  
Postoperative physiologic metabolic derangements is a potentially life-threatening 
complication in surgical care. This PSI encompasses codes for ketoacidosis, 
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hyperosmolarity, or other coma, diabetes, acute renal failure, acute myocardial infarction, 
cardiac arrhythmia, cardiac arrest, shock, hemorrhage, or gastrointestinal hemorrhage.
104
 
The project team developing the AHRQ PSIs conducted extensive empirical analyses on 
this PSI. The team concluded that this PSI generally performs well on several different 
dimensions, including reliability, bias, relatedness of indicators, and persistence over 
time.
101
 AHRQ panellists had a concern about the definition of acute renal failure: what 
one doctor may call acute renal failure, another may not. To ensure that the only renal 
failure cases that are accounted for are those that are clinically severe, the panel 
suggested that acute renal failure be included only when it is paired with a procedure 
code for dialysis.
101
 Panellists also noted that coding of relatively transient metabolic and 
physiologic complications may be lacking, e.g. cases of diabetic ketoacidosis. 
Conversely, some physicians may capture non-clinically significant events in this 
indicator.
101
 
Postoperative respiratory failure (PSI 11)  
A study on multifactorial risk index for predicting postoperative respiratory 
failure in men after major noncardiac surgery found that 5% to 10% of all surgical 
patients and 9% to 40% of those undergoing abdominal surgery experience postoperative 
pulmonary complications.
105
 Postoperative respiratory failure was defined as mechanical 
ventilation for more than 48 hours after surgery or reintubation and mechanical 
ventilation after postoperative extubation, which is the most common definition for this 
adverse event.  
Prior studies have suggested that the risk factors for postoperative respiratory 
failure include those that are patient-specific and those that are operation-specific. 
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Patients with increased chance of developing postoperative respiratory failure include 
those who have the following risk factors: impaired general health status (e.g., older age, 
poor functional status, diabetes mellitus, cancer, alcohol use), pulmonary (e.g., smoking, 
chronic obstructive pulmonary disease [COPD], increased body mass index), neurologic 
(e.g., impaired sensorium), and cardiac disorders (e.g., myocardial infarction), and renal 
and fluid status (e.g., renal failure, blood transfusion). The operation-specific risk factors 
include the location of the incision in relation to the diaphragm, emergent operation, and 
the type of anesthesia used (e.g., general vs. spinal).
105
 
Johnson et al
106
 found that 28 variables were found to be independently associated 
with postoperative respiratory failure. Patients with a higher American Society of 
Anesthesiologists classification, emergency operations, more complex operation  as 
measured by work relative value units, preoperative sepsis, and elevated creatinine were 
more likely to experience Postoperative respiratory failure. Older patients, male patients, 
smokers, and those with a history of congestive heart failure or COPD, or both, were also 
predisposed.
106
  
Postoperative pulmonary embolism or deep vein thrombosis (PSI 12) 
The occurrence of postoperative pulmonary embolism (PE) or deep vein 
thrombosis (DVT) can range from mild symptoms to fatal clinical consequences 
including pain, respiratory distress, and death. PE/DVT can be prevented through the 
appropriate use of anticoagulants and other preventive measures. The identification and 
stratification of patients at risk for venous thromboembolism is critical.  Despite 
numerous studies demonstrating the efficacy and safety of prophylaxis, it is still 
underused and most patients who die from pulmonary embolism do so within 30 minutes 
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of the acute event, which is far from sufficient time for anticoagulation to be effective.
107
 
Thus, PE or DVT is a suitable measure of patient safety. 
Postoperative sepsis (PSI 13) 
Sepsis is a severe complication of surgical procedures with a mortality rate of up 
to 30%.
101
 Typically, many cases of postoperative sepsis can be prevented through the 
appropriate use of antibiotics, good preoperative preparation, careful and sterile surgical 
techniques and good post-operative care.
101
 Thus, PSI 13 is a suitable measure of patient 
safety. 
Accidental puncture and laceration (PSI 15)  
Accidental puncture or laceration is an important and potentially life-threatening 
complication in surgical care.
101
 Thus, it is a suitable measure of patient safety. 
In-hospital Mortality 
In-hospital mortality has been used as a common measure for evaluating the 
quality of surgical procedures.
27, 108-118
 Improvements in CABG technique have resulted 
in a steady decline in the risks of the procedure and, subsequently in around 2% mortality 
rates nationwide with steady decline since the 1990s.
27, 119
 In the present study, in-
hospital mortality has been identified in the HIDD as ‗expired‘ (coded 20) under the 
discharge status. Crude in-hospital mortality rate for CABG was 2.59% (n=3,096 out of 
119,664 patients originally included in the study). 
A summary of the clinical relevance of the selected PSIs to CABG and the 
rationale for measuring surgical outcomes by these indicators is provided in Exhibit 3.1.  
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Exhibit 3.1: Clinical Relevance of the Selected PSIs to CABG Surgery 
Patient Safety Indicators (PSI) 1 2  3 4 5 
PSI 4  
Failure to rescue 
 
 
    √ √ 
PSI 5  
Foreign body left in during procedure 
 √ √  √ 
PSI 6  
Iatrogenic pneumothorax 
√ √    
PSI 7  
Selected infections due to medical care 
  √  √ 
PSI 9  
Postoperative hemorrhage or hematoma 
 √ √   
PSI 10  
Postoperative physiologic and metabolic 
derangement 
 √ √   
PSI 11  
Postoperative respiratory failure 
  √ √ √ 
PSI 12  
Postoperative PE/ DVT 
 √ √ √  
PSI 13  
Postoperative sepsis 
 √ √ √  
PSI 15  
Accidental puncture or laceration 
 √ √   
1=clinical relevance to chest surgery  
2=technical proficiency/skills of the operating surgeon 
3= technical proficiency/skills of the operating team  
4=postoperative care  
5=hospital/organizational factors  
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Independent/Predictor Variables 
Patient Characteristics 
Demographic factors: age (continuous), sex (binary), race/ethnicity (categorical), 
pay source, type of admission and binary indicators for 30 comorbidities.  
All above listed variables were included in the HIDD except comorbidities. To 
generate comorbodities the comorbidity software, version 3.0, was obtained from the 
Agency for Healthcare Research and Quality 
(http://www.hcupus.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp#download). The 
comorbidity measure used by the software was developed by Elixhauser and colleagues 
to predict length of hospital stay, total charges and in-hospital mortality.
120
 Extensive 
body of literature has examined the adequacy of administrative data for measurement of 
comorbidity and risk adjustment.
121
 Main concerns are the inherent limitations with 
regard to distinguishing in-hospital complications from comorbid conditions, accuracy 
and variations in coding of diagnoses across hospitals.  
Only several of the 30 comorbidities were included in the analysis based on their 
clinical relevance. These comorbidities were congestive heart failure (CHF), chronic 
pulmonary disease, diabetes with chronic complications, hypertension, pulmonary 
circulation disease, valvular disease and liver disease. All of these conditions were 
selected based on the chronicity of their nature and evidence for increased risk for 
surgery.  
It is well-documented that history of CHF is associated with increased risk of 
perioperative cardiac and extracardiac complications, morbidity and mortality.
122-125
 In 
50 
 
addition, patients with CHF may require prolonged postoperative mechanical 
ventilation126 or conversion of off-pump to on-pump CABG.
127
 
Similarly, valvular heart disease can be associated with increased perioperative 
cardiac risk.
128
 Specifically, patients with aortic stenosis are at greatest risk – severe 
aortic stenosis leads to a 14-fold increase in sudden death due to the potential for severe 
decrease in cardiac output.
122
 Other valvular diseases such as aortic insufficiency, mitral 
stenosis, mitral regurgitation as well as prosthetic valves also carry the risk of increased 
perioperative complications including left ventricular failure, severe pulmonary 
congestion, endocarditis and thromboembolic phenomena.
122, 128
 Severe hypertension 
(diastolic BP >110 mm/Hg) may be associated with some increased postoperative risk.
122
  
Studies have found that patients with diabetes mellitus have increased rates of 
cardiovascular morbidity and mortality.
129, 130
 In addition, diabetic patients with identified 
complications, such as nephropathy and peripheral arteriosclerosis, have the highest 
mortality after heart surgery.
131
 In general, there is a twofold increase in both early and 
late mortality among diabetic patients compared to those who do not have diabetes.
122
  
Chronic pulmonary disease includes several conditions affecting the blood 
circulation in the lungs such as chronic thromboembolic disease, pulmonary arterial 
hypertension, pulmonary veno-occlusive disease, arteriovenous malformations and 
pulmonary edema. Patients with pulmonary hypertension are at increased risk of 
perioeperative complications including hypoxia, right ventricular failure, and ischemia.
132
 
These risks are especially high for cardiac surgery
133
  increasing mortality rates up to 
25%.
132
 Chronic thromboembolic pulmonary disease is one of the leading causes of 
severe pulmonary hypertension and progressive right heart failure.
134
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Studies have found that patients with chronic liver disease are at higher risk of 
mortality and complications during surgery.
135, 136
 Specifically, risk factors for 
perioperative death for patients with liver disease included a low hematocrit (< 30%), an 
elevated serum bilirubin (>11 mg/dL), and a malignant cause of biliary obstruction. The 
mortality rate was 60% when all three were present vs. only 5% when none were 
present.
136
  
Four comorbidities that are highly relevant to CABG surgery were not entered in 
the models due to their potential of being a post-surgical complication rather than a pre-
existing condition. These comorbidities were: (1) other neurological disorders – 
numerous studies find that neurologic complications are second only to heart failure as a 
cause of morbidity and mortality following cardiac surgery.
137-139
 The chance of 
neurological dysfunction as a surgical complication is particularly high when CPB is 
involved despite the recent advances in cardiopulmonary bypass technology, surgical 
techniques and anaesthetic management;
140
 (2) renal failure – the risk of renal failure 
after cardiopulmonary bypass ranges from 3% to 31%, depending on the classification 
used;
141
 (3) coagulopthy – major changes may occur in the coagulation system during 
cardiopulmonary bypass
142
 and studies have documented a wide variety of derangements 
in laboratory measurements of blood coagulation during cardiopulmonary bypass;
143
 (4) 
fluid and electrolyte disorders –CPB can cause multiple electrolyte disturbances.
144
 
Cardioplegic solutions and induced hypothermia impose alterations in potassium 
metabolism and pH, dilution of the circulating blood volume from pump perfusate and 
volume resuscitation with crystalloid and colloid solutions produce fluid, electrolyte, and 
hemostatic disorders.
144
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TABLE 3.4: Patient Comorbidities (Elixhauser Comorbidities 
Based on ICD-9-CM codes) 
Variable description Codes/Values 
Acquired immune deficiency syndrome 1= Yes, 0= No 
Alcohol abuse 1= Yes, 0= No 
Deficiency Anemias 1= Yes, 0= No 
Rheumatoid Arthritis 1= Yes, 0= No 
Chronic blood loss anemia 1= Yes, 0= No 
Congestive Heart Failure  1= Yes, 0= No 
Chronic Pulmonary Disease 1= Yes, 0= No 
Depression 1= Yes, 0= No 
Diabetes mellitus without chronic 
complications 
1= Yes, 0= No 
Diabetes mellitus with chronic complications 1= Yes, 0= No 
Drug abuse 1= Yes, 0= No 
Hypertension 1= Yes, 0= No 
Hypothyroidism 1= Yes, 0= No 
Liver disease 1= Yes, 0= No 
Lymphoma 1= Yes, 0= No 
Metastatic cancer 1= Yes, 0= No 
Obesity 1= Yes, 0= No 
Paralysis 1= Yes, 0= No 
Peripheral vascular disease 1= Yes, 0= No 
Psychoses 1= Yes, 0= No 
Pulmonary circulation disease 1= Yes, 0= No 
Solid tumor w/out metastasis 1= Yes, 0= No 
Valvular disease  1= Yes, 0= No 
Weight loss 1= Yes, 0= No 
 
 
 
All patient characteristic variables were coded as categorical variables. The 
referent group was the group with the most observations or/and the least risk associated 
with the outcomes of interest. As listed in Table 3.5, age was categorized into the 
following groups: 30-39, 40-49, 50-59, 60-69, 70-79 (referent), 80 and over.  Elective 
admission was the referent group for admission type, whites were the referent group for 
race, men for gender. 
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Surgeon Characteristics  
The analysis initially included 264 surgeons with verified board certification 
either in general surgery or thoracic surgery. Two surgeons with exact same number of 
CABG surgeries were excluded to allow creation of four categories (surgeons who 
performed 100% on- or off-pump CABG and those who performed mostly on- or off-
pump CABG). However, one of these categories (100% off-pump CABG) was 
eliminated entirely due to subsequent exclusion of surgeons who performed only one 
procedure over the entire study period (n=32).  
The definition and coding of all variables characterizing 230 surgeons remaining 
in the analytic sample are presented in Table 3.5. Medical education and practice 
information was obtained from PPDF. Location of surgeon was determined based on 
Rural-Urban Commuting Area Codes (RUCAs) obtained from the 2000 US Census.  
Total procedure volume was measured as total number of CABG cases performed 
by each board certified thoracic or general surgeon over 7-year study period, which was 
also defined as cumulative volume.  
Further, surgeon volume was assessed by ranking all surgeons into quartiles based 
on their CABG, CCABG and OPCABG operations.  Surgeon case volumes in the off-
pump models were based only on procedures performed off-pump, and surgeon case 
volumes in the on-pump models were based only on procedures performed on-pump.  
Hospital volume was based on the total number of off-pump and on-pump CABG 
procedures performed at a particular hospital. 
Models were developed with patient volume quartiles as categorical variables for 
each of the volume measures, with the highestvolume quartile used as the reference 
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category (for both surgeons and hospitals). Model coefficients for the other three volume 
quartiles were used to estimate the risk-adjusted mortality for those quartiles relative to 
the highest-volume quartile. Next, lowest volume surgeons were identified by obtaining 
univariate distribution of the CABG volume. There was a break at 1% of surgeons who 
did 88 procedures, which was considered to be the lowest volume. 
Hospital Characteristics  
Hospital variables included hospital CABG volume expressed as volume 
quartiles, hospital teaching and ownership status (public, not-for-profit, investor-owned), 
total discharges, location (urban vs. rural) and bed size (Table 3.5). For all variables a 
category with the most observations was referent in both anadjsuted and adjusted 
analyses. For hospital CABG volume a referent category was quartile 4, for teaching 
status – non-teaching hopistals, for ownership not-for-profit hospitals, for total discharges 
hospitals with 29,292 – 52,006 dischargres, for bed size – 500 and more beds, for 
location – urban hospitals. 
 
TABLE 3.5: Definition of Variables and Coding 
Variable  Definition 
Patient age  30-39 
 40-49 
 50-59 
 60-69 
 70-79 
 80+ 
  
Patient gender Man  
 Woman  
  
Patient race/ethnicity  Black, non-Hispanic 
 White, non-Hispanic 
 Hispanic 
 Other 
55 
 
TABLE 3.5 (continued)  
Variable  Definition  
Primary payer Medicare 
 Medicaid 
 Commercial insurance 
 Self-pay/Charity 
 Other 
  
Admission type Elective   
 Emergency 
 Urgent     
 Other      
  
Patient comorbidities  Comorbid conditions identified by 
applying Elixhauser Comorbidity 
Algorithm based on ICD-9-CM codes 
 Individual 24 comorbidities and 
number of comorbidities  
  0 
  1 
  2 
  3 or more 
  
Surgeon board certification ABS (American Board of Surgery)  
 ABTS and ABTS (dual certification 
obtained from American Board of 
Surgery and American Board of 
Thoracic Surgery)  
 ABTS (American Board of Thoracic 
Surgery) 
  
Years since medical school graduation 0-10 
 
 
11-20 
 21-30 
 31+ 
 Unknown 
 Mean(SD) 
  
Years practicing 0-10 
 11-20 
 21-30 
 31+ 
 Unknown 
 Mean(SD) 
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TABLE 3.5 (continued)  
Variable  Definition  
Medical school location US  
 Foreign  
 Unknown  
  
County physician located Metropolitan 
 Non-metropolitan 
 Out of state 
 
Surgeon total CABG volume All CABG procedures per surgeon 
 Quartile 1 
 Quartile 2 
 Quartile 3 
 Quartile 4 
  
Surgeon CCABG volume All on-pump CABG procedures 
performed by a surgeon 
 Quartile 1 
 Quartile 2 
 Quartile 3 
 Quartile 4 
  
Surgeon OPCABG volume All off-pump CABG procedures 
performed by a surgeon 
 Quartile 1 
 Quartile 2 
 Quartile 3 
 Quartile 4 
  
Hospital total CABG volume All CABG procedures per hospital  
 Quartile 1 
 Quartile 2 
 Quartile 3 
 Quartile 4 
 
Hospital teaching status Non-teaching  
 Teaching 
  
Hospital Ownership status  Investor-owned 
 Not-for-profit 
 Public  
  
  
  
  
57 
 
TABLE 3.5 (continued)  
Variable  Definition  
Hospital Bed size Less than 200 
 200-299 
 300-399 
 400-499 
 500+ 
  
Total hospital discharges 582-13,209  
 13,210-29,291 
 29,292-52,006 
  
Hospital Location Urban  
 Rural  
CCABG=Conventional Coronary Artery Bypass Graft, OPCABG=Off-pump 
Coronary Artery Bypass Graft 
 
 
Data Analysis 
Univariate analysis included frequencies (n, %) for categorical variables and 
means and standard deviations for continuous variables. Bivariate analysis used Chi 
square test to examine differences between patient and surgeon characteristics.  
The data structure was hierarchical as it contained nesting of patients within 
surgeons and nesting of surgeons within hospitals. To address this issue of non-
independence multilevel modeling of hierarchical data was used for the present study. 
The method was selected as it enables to model variability at each level of the hierarchy. 
The response is measured at the individual level, and includes both the effect of that 
individual and the effect of the context. Consequently, the regression coefficient is an 
estimate of how the outcome changes as a function of predictors conditional on the 
random effects.
145
 The GLIMMIX procedure used for the analysis incorporates random 
effects in the model thus allowing for subject-specific (conditional) and population-
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averaged (marginal) inference.
146
 Predictor variables for the three levels of hierarchical 
data included: level 1 predictors – patient age, race, residence, gender, insurance type, 
admission type, number of comorbidities; level 2 predictors – surgeon specialty 
certification, years in practice, CABG volume (total, CCABG and OPCABG) expressed 
in quartiles; level 3 predictors – hospital ownership (public, private), teaching status, total 
discharges, total CABG volume (expressed in quartiles), bed size, location (urban vs. 
rural).  
All statistical analyses were conducted using SAS release 9.2 (SAS Institute Inc., 
Cary, NC) with P<.05 considered statistically significant.  
Hypothesis 1.1 
 Four separate models were fit to assess the effect of procedure-specific CABG 
volume on each outcome measure (Table 3.6, models 1.1a – 1.1d). The sample was 
grouped by off-pump and on-pump CABG, and models were fit to assess each outcome 
for off-pump CABG and on-pump CABG patients separately. Eight surgeons performing 
exclusively CCABG were not included in the analysis (surgeons n=222, discharges 
n=119,403, CCABG cases n=94,808, OPACABG cases n=24,595). 
Hypothesis 1.2 
 A dummy variable was created for surgeons with total CABG volume of ≤88 
procedures over 7 years. The cut point of ≤88 procedures was obtained from univariate 
distribution of the CABG volume. There was a gap from 2 procedures to 88 procedures 
perfomed by 1% of surgeons. Thus, ≤88 procedures over the 7-year study period was 
considered be the lowest volume (Table 3.6, models 1.2a and 1.2b). The analysis did not 
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adjust for any other surgeon volume covariates including on-pump or off-pump volume 
quartiles.  
Hypothesis 1.3 
 Similar to the analysis conducted to test Hypothesis 1.1, four separate models 
were fit to assess the effect of total 7-year CABG volume (cumulative volume) and 
proportional (off-pump vs. on-pump CABG) CABG volume (Table 3.6, models 1.3a and 
1.3b).   
Hypothesis 2.1 
If surgeon was in the lowest total CABG quartile and hospital was in the total 
CABG quartile 3 or 4 and had highest number of total discharges then the ‗low volume 
MD in high volume hospital‘ variable was created. If surgeon was in the lowest total 
CABG quartile and hospital was in the total CABG quartile 1 or 2 and had the lowest 
number of total discharges then the ‗low volume MD in low volume hospital‘ variable 
was created and both variables were entered in the multilevel models. The analyses were 
adjusted for patient characteristics, surgeon board certification and experience and 
hospital ownership and teaching status (Table 3.6, models 2.1a and 2.1b).   
Hypothesis 2.2 
Analyses were adjusted for patient risk factors and hospital characteristics 
including bed size, total discharges, total CABG volume (expressed in quartiles) and 
ownership and teaching status (Table 3.6, models 2.2a and 2.2b).   
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TABLE 3.6: Description of Models  
Hypothesis Model Type Model No 
H1.1 
 
Mortality ~ patient age, race/ethnicity/sex, admission 
type, comorbidities, + surgeon volume (all CABG 
cases, and on-pump CABG cases) + surgeon 
certification + surgeon practice+ hospital CABG 
volume, teaching status , ownership, location, bed 
size, total discharges  
1.1a 
   
 Complications ~ patient age, race/ethnicity/sex, 
admission type, comorbidities, + surgeon volume (all 
CABG cases, and on-pump CABG cases) + surgeon 
certification + surgeon practice+ hospital CABG 
volume, teaching status , ownership, location, bed 
size, total discharges 
1.1b 
   
 Mortality ~ patient age, race/ethnicity/sex, admission 
type, comorbidities, + surgeon volume (all CABG 
cases, and off-pump CABG cases) + surgeon 
certification + surgeon practice+ hospital CABG 
volume, teaching status , ownership, location, bed 
size, total discharges 
1.1c 
   
 Complications ~ patient age, race/ethnicity/sex, 
admission type, comorbidities, + surgeon volume (all 
CABG cases, and off-pump CABG cases) + surgeon 
certification + surgeon practice+ hospital CABG 
volume, teaching status , ownership, location, bed 
size, total discharges 
1.1d 
 
H1.2 
 
Mortality ~ patient age, race/ethnicity/sex, admission 
type, comorbidities, + surgeon volume (≤88  CABG 
cases) + surgeon certification + surgeon practice+ 
hospital CABG volume, teaching status , ownership, 
location, bed size, total discharges 
1.2a 
   
 Complications ~ patient age, race/ethnicity/sex, 
admission type, comorbidities, + surgeon volume 
(≤88  CABG cases) + surgeon certification + surgeon 
practice+ hospital CABG volume, teaching status , 
ownership, location, bed size, total discharges 
1.2b 
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TABLE 3.6 (continued) 
Hypothesis Model Type Model No 
H1.3 
 
Mortality ~ patient age, race/ethnicity/sex, admission 
type, comorbidities, + cumulative surgeon volume 
(all CABG cases, 2000-2006) + surgeon certification 
+ surgeon practice+ hospital CABG volume, teaching 
status , ownership, location, bed size 
1.3a 
   
 Complications ~ patient age, race/ethnicity/sex, 
admission type, comorbidities, + cumulative surgeon 
volume (all CABG cases, 2000-2006) + surgeon 
certification + surgeon practice+ hospital CABG 
volume, teaching status , ownership, location, bed 
size 
1.3b 
   
H2.1 Mortality ~ patient age, race/ethnicity/sex, admission 
type, comorbidities, + LVMD/HVH + LVMD/LVH + 
surgeon certification + surgeon practice + teaching 
status + ownership + location + bed size 
2.1a 
   
 Complications ~ patient age, race/ethnicity/sex, 
admission type, comorbidities, + LVMD/HVH + 
LVMD/LVH + surgeon certification + surgeon 
practice + teaching status + ownership + location + 
bed size 
2.1b 
   
H2.2 
 
Mortality ~ patient age, race/ethnicity/sex, admission 
type, comorbidities, + hospital CABG volume, 
teaching status , ownership, location, bed size, total 
discharges 
 
2.2a 
 Complications ~ patient age, race/ethnicity/sex, 
admission type, comorbidities, + hospital CABG 
volume, teaching status , ownership, location, bed 
size, total discharges 
2.2b 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4: RESULTS 
 
 
Descriptive Statistics 
The study population included 119,559 patients undergoing isolated CABG 
surgery in Florida who were discharged from the hospital between 2000 and 2006. The 
sample was restricted to patients ages 30-80 and over. These patients were treated by 230 
surgeons (meeting the study inclusion criteria) working at 80 hospitals. Overall, 94,964 
(79.43%) of the CABG procedures were performed on-pump and 24,595 (20.57%) off-
pump. Of the 230 surgeons in the study cohort, 222 performed ≥2 on- or off-pump 
CABG procedures over the 7-year period, and eight performed exclusively on-pump 
CABG.  
Patient Characteristics 
Patients demographic characteristics – age, sex, race/ethnicity, insurance status 
and type of admission included in the analyses are described below (Table 4.1). Overall, 
the patients operated on by board certified general and thoracic surgeons had a mean age 
of 66 (10.68) years. Largest proportion of patients were 70–79 years of age (33.65%) 
followed by those in 60 -69 age category (30.08%). In addition, 72.13% were male 
(n=86237) white (82.49 %), had Medicare insurance (59.52 %) and were admitted 
electively (40.79%). 
Further, as displayed in Table 4.1 larger proportion of patients undergoing both 
types of CABG - CCABG and OPCABG were white (83.21% and 79.69% respectively, 
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p<0.0001), male (72.88% and 69.22% respectively, p<0.0001), ages of 70-79 (34.04% 
and 32.15% respectively, p<0.0001), Medicare beneficiaries (59.72% and 58.76% 
respectively, p<0.0001) and admitted electively (40.51% and 41.87% respectively, 
p<0.00).  
Table 4.2 shows patient characteristics by total CABG volume quartiles. Quartile 
1 (low volume) surgeons operated on higher proportion of non-Hispanic black and 
Hispanic patients (8.16% and 18.06%) and Medicaid (7.36%) and uninsured or 
underinsured patients (9.78%) compared to surgeons in other three CABG volume 
quartiles. Higher proportion of white patients was seen by quartile 3 and 4 surgeons 
(85.16% and 82.17% respectively) as well as Medicare and commercially insured 
patients compared to other CABG volume categories. The distribution of patients across 
all CABG volume quartiles was similar with regard to sex, age, and number of comorbid 
conditions.   
The comorbid conditions (selected from original 30 comorbidities included in the 
algorithm developed by Elixhauser et al
120
) for the patients included in the study and 
stratified by CABG technique are reported in Table 4.3. Overall, 9.33% of patients had 
no comorbidities, 26.94% had at least one comorbidity, and over 30% had two 
comorbidities or more. The major comorbidities for CABG patients were hypertension 
(65.48%), diabetes mellitus without chronic complications (26.7%), chronic pulmonary 
disease (22.73%), congestive heart failure (18.95%), valvular disease (11.65%), 
deficiency anemias (11.53%) and peripheral vascular disease (11.24%). 
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Surgeon Characteristics 
Table 4.4 presents surgeon characteristics for 262 surgeons by original surgeon 
categories (100% on- or off-pump CABG and mostly on- or off-pump CABG). Largest 
proportion of surgeons performed both types of CABG with those providing mostly 
CCABG being the biggest category with 190 surgeons (92.5%). Only 32 (12.2%) 
surgeons provided OPCABG more frequently than CCABG; 26 (9.9%) and 14 (5.3%) 
surgeons provided exclusively CCABG and OPCABG operations. The distribution of 
surgeons with respect to years since graduation from medical school, years in practice 
and practice and medical school location was quite similar across all categories.  
As shown in Table 4.5,  exclusively OPCABG surgeons had very few number of 
cases during the study period (n=14, 0.01%). Their patients were predominantly white 
(78.6%), male (85.7%), 60-69 years of age and Medicare beneficiaries (64.3%). 
Distribution was similar for all other groups with several exceptions: larger proportion of 
patients of exclusively CCABG, predominantly CCABG and OPCABG surgeons were 
70-79 years of age (33.5%, 34.3%, and 31.8% respectively). In addition, majority of 
operations (87.88%) were performed by surgeons who did mostly CCABG. Overall, 
largest proportion of CABG was performed by surgeons that were providing both types 
of CABG – on-pump and off pump. Surgeons with the preference of performing 
OPCABG operated on 11.96% of patients and only 0.16% and 0.01% of patients were 
operated on by surgeons who provided exclusively on-pump or off-pump surgery 
respectively.  
After excluding 32 surgeons due to extremely small number of procedures over 7-
year study period OPCABG category was eliminated as all 14 surgeons in this category 
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were excluded. As reported in Table 4.6 out of remaining 230 surgeons 16 (6.96%) were 
board certified by American Board of Surgery (ABS), 90 surgeons (39.13%) had 
obtained dual certification by ABS and American Board of Thoracic Surgery (ABTS) 
while majority of them 124 (53.91%) were ABTS certified surgeons. In addition, higher 
proportion of surgeons were in practice for 11-20 years (29.57%), US graduates (96.52%) 
and had graduated from medical school 11-20 years ago (36.65%). After stratifying 
surgeons based on their performance of CCABG or OPCABG this distribution remained 
similar, except certification status. Larger proportion of surgeons performing OPCABG 
was dually certified (47.17%) compared to ABTS certified surgeons (45.28%).   
In addition, highest proportion of surgeons included in the study practiced at one 
hospital 79 (34.35%), 58 surgeons (25.22%) practiced at two hospitals and 41 (17.83%) 
at three hospitals, 52 surgeons (22.60%) at 4 and more hospitals (Table 4.7).  
Table 4.9 shows surgeon workload and their patient demographics by four 
surgeon volume quartiles. Surgeons in quartile 1 performed 2,729 CABG procedures; 
quartile 2, 3 and 4 surgeons performed 15,278, 37,145 and 64,417 procedures 
respectively. Average total CABG, CCABG and OPCABG volume was largest among 
surgeons in quartile 4 volume category 164.47(34.37), 130.11(49.01) and 34.36(36.85) 
respectively with their OPCABG volume being markedly smaller compared to total and 
CCABG volume (p<0.0001).  
ABS and dually certified (ABS and ABTS) surgeons with the largest patient 
workload were in quartile 2 (8.06% and 44.23% respectively, p<0.0001) while ABTS 
certified surgeons in quartile 4 operated on the largest proportion of patients (67.08%). 
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Overall, ABTS certified surgeons had larger patient workload in all volume quartiles 
compared to physicians with other certification status (ABS or dual certification).  
Surgeons with fewer years in practice (0-10 and 11-20) with higher patient 
workload were in lower volume quartiles (1 and 2), (17.03% and 39.50% respectively) 
while with the increasing experience (31 and more years in practice) their patient 
workload decreased with the volume increase, in a linear fashion: 14.01%, 11.34%, 
8.33% and 7.57% for quartile 1, 2, 3 and 4 respectively (p<0.0001). 
With respect to years since graduation surgeons‘ patient workload increased 
markedly for the higher volume quartiles (3 and 4) for those with 11-20 and 21-30 years 
since graduation while it decreased for those with 0-10 and 31 and more years since 
graduation for the same volume quartiles (p<0.0001). In addition, surgeons with highest 
patient workload in all four quartiles were US graduates.  
Hospital characteristics 
The hospital characteristics including hospital CABG volume, ownership and 
teaching status, location (urban vs. rural), bed size and total discharges for the population 
used in the analyses are described below (Table 4.8). Largest proportion of patients were 
operated on at not-for-profit (56.52%, p<0.0001) non-teaching (76.96%, p<0.0022), 
urban (88.06%, p<0.0001) hospitals with over 500 beds (44.21%, p<0.0001) and total 
hospital discharges ranging between 13,210 and 29,291 (49.43%, p<0.0001).  
Table 4.10 displays patient and hospital characteristics as a function of hospital 
volume. Compared with higher-volume centers, lowest-volume hospitals (quartile 1 and 
2) were more likely to operate on older patients (11.70%, p<0.0001 ) who were non-
Hispanic Black (4.60% for quartile 1 and 7.24% for quartile 2 vs. 5.60% and 3.79% for 
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quartiles 3 and 4 respectively, p<0.0001) or Hispanic (5.32% - quartile 1 and 18.18% - 
quartile 2 vs. 8.14% and 5.13% for quartiles 3 and 4 respectively, p<0.0001), had 3 or 
more comorbid conditions (36.18% - quartile 1, vs. 34.05% and 30.99% in quartiles 3 
and 4 respectively, p<0.0001) and unscheduled (emergency) surgery (30.24% - quartile 1, 
35.10% - quartile 2 vs. 28.43% and 22.23% for quartiles 3 and 4 respectively, p<0.000). 
Outcomes 
Overall, in-hospital mortality and complications for CABG patients operated by 
general surgeons and thoracic surgeons was 2.59 % and 3.29% respectively.  
Complications (any PSI)  
As shown in Table 4.11, greater proportion of patients having a complication was 
male (67.57%, p<0.0001), ages of 70-79 (37.97%, p<0.0001), had Medicare (67.24%, 
p<0.0001), and had one or two of the selected Elixhauser comorbidities (31.33% and 
31.13%, respectively p<0.0001).  
In addition, as reported in table 4.12, compared to patients with no complications, 
those having any PSI were operated by low volume (total CABG quartile 1 and 2) 
surgeons (2.80% vs. 2.26% and 13.72% vs. 12.75% respectively, p=0.0208), while for 
surgeons in quartile 3 and 4 the rate of complications were almost same and lower 
(31.28% vs. 31.06% and 52.20% vs. 53.93% respectively, p=0.0208). With regard to 
specific CABG volume, patients who were operated by CCABG volume quartile 1, 2 and 
3 surgeons had higher rates of complications (3.56 vs. 2.88, 17.00 vs. 16.28 and 32.25 vs. 
29.42 respectively, p<0.0001). Only CCABG quartile 4 surgeons achieved lower rates of 
complications (47.19 vs. 51.41, p<0.0001). For patients operated by surgeons categorized 
in OPCABG volume quartiles, there was no obvious trend or any significant differences 
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between the patients with and without complications in any volume quartiles (p=0.0697). 
Furthermore, the patients operated by ABS certified general surgeons had higher rates of 
complications (2.42% vs. 1.89%, p=0.0277) while patients of those surgeons that had 
obtained ABTS certification (either in addition to ABS certification or alone) had similar 
or lower complication rates (36.93% vs. 36.18% and 60.65% vs. 61.93%, p=0.0009). The 
differences were also observed between patients with and without complications based on 
surgical training. Patients of surgeons who had graduated from medical school 11-20 
years ago had lower rate of complications (37.72% vs. 40.59%, p=0.0050) while patients 
of surgeons at two extremes of medical school graduation (i.e. 0-10 and 31 and more 
years) had higher rates of complications   (16.03% vs. 15.48% and 12.83% vs. 11.59% 
respectively, p=0.0050). Similarly, patients of surgeons practicing for 11-20 years had 
lower rates of complications (29.12% vs. 30.24%, p=0.0002).  
The differences in complication rates based on hospital characteristics where 
patients were operated were significantly different based on ownership status: patients 
operated in not-for-profit and investor-owned hospitals had lower rates (55.92% vs. 
56.54% and 27.87% vs. 28.74% respectively, p=0.0296) while public hospitals had 
higher complication rates (16.21% vs. 14.72%, p=0.0296) 
Mortality   
Patient distribution with regard to mortality was quite similar to that of 
complications (Tables 4.11 – 4.12): patients in the age group of 70-79 (43.39%, 
p<0.0001) males (62.15%, p<0.0001), and Medicare beneficiaries had higher rates of 
mortality. Furthermore, patients operated by lower total CABG volume surgeons (quartile 
1 and 2) had higher mortality rates (2.55% vs. 2.27% and 14.35% vs. 12.27% 
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respectively, p=0.0362). The trend was, however, reversed for patients seen by the 
quartile 3 and 4 surgeons (30.14% vs. 31.09% and 52.97% and 53.90% respectively, 
p=0.0362). Similar pattern was observed for patients seen by surgeons CCABG quartile 
1, 2 and 4. However, those seen by CCABG quartile 3 surgeons still had higher rates of 
mortality (32.53% vs. 29.43%, p<0.0001). There was no clear trend in mortality for 
patients operated on by surgeons in OPCABG quartiles and the differences did not reach 
the level of significance.  
Interesting pattern was observed among the patient mortality outcomes with 
regard to surgeon certification. Those operated by ABS certified surgeons had higher 
mortality rates (2.80% vs. 1.88%); similar rates were noted for patients of dually certified 
surgeons (36.40% vs. 36.20%) and lower rate of ABTS certified surgeons (60.80% vs. 
61.92%), p= 0.0009. In addition, patients seen by surgeons with highest number of years 
since graduation and years practicing (31 and more) had higher proportion of mortality 
(14.89% vs.11.53%, p<0.0001and 10.28% vs. 8.39%, p<0.0001).     
No significant differences were observed in mortality rates for patients with 
respect to hospital teaching and ownership status and total CABG volume.  
Unadjusted Results for the Independent Variables and Each Outcome 
Tables 4.13 – 4.14 report unadjusted results for the independent variables and the 
outcomes of interest.  
Unadjusted Results for Patient Characteristics 
Patients in all age groups except 80 years of age and over had lower odds of 
complications and mortality compared to those in the 70-79 age category. Out of these 
groups only odds of complication for 30-39 year-olds was not significant (p=0.0728). 
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Females had 60% higher odds of mortality (OR=1.60, 95% CI: 1.49-1.72) and 25% 
higher odds of complications (OR=1.25, 95% CI: 1.17-1.34) compared to males. 
Although whites represented about 80% of the study sample, all minority groups had 
higher unadjusted odds of mortality although it did not reach the level of significance.   
Unadjusted Results for Provider Characteristics  
As Table 4.14 shows, patients operated by surgeons in lower total CABG 
quartiles (1 and 2) had significantly higher odds of complications (OR=1.28, 95% CI: 
1.05-1.55 and OR=1.11, 95% CI: 1.01-1.23 respectively) compared to highest CABG 
volume surgeons (quartile 4). Patients seen by quartile 2 surgeons also had significantly 
higher odds of mortality (OR=1.15, 95% CI: 1.03-1.28) compared to quartile 4 surgeons. 
The volume effect was even more pronounced for patients operated by CCABG quartile 
1, 2 and 3 surgeons: they had higher odds of complications (OR=1.47, 95% CI: 1.34-
1.62, OR=1.34, 95% CI: 1.22-1.48 and OR=1.38, 95% CI: 1.25-1.52 respectively) and 
mortality (OR=1.30, 95% CI: 1.18-1.44, OR=1.23, 95% CI: 1.10-1.36 and OR=1.12, 
95% CI: 1.01-1.25 respectively) compared to the patients of the highest CCABG volume 
surgeons. No clear association was found among patients across OPCABG surgeon 
quartiles except the only significant association between lower odds of complications 
(OR=0.90, 95% CI: 0.83-0.97) for quartile 3 compared to quartile 4. 
Furthermore, patients operated by ABS certified surgeons had significantly higher 
odds of complications (OR=1.31, 95% CI: 1.06-1.61) and mortality (OR=1.52, 95% CI: 
1.22-1.89) compared to patients of ABTS certified surgeons while there was no 
difference for the outcomes of dually certified physicians.  
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Consistent trends in outcomes emerged based on practice patterns of operating 
physicians. Patients seen by surgeons on either extreme of experience expressed as years 
in practice and years since graduation had significantly higher odds of complications and 
mortality. Specifically, patients operated by surgeons with 0-10 years since graduation 
had higher odds of complications (OR=1.11, 95% CI: 1.01-1.22) as well as those treated 
by 31 years and over since graduation (OR=1.19, 95% CI: 1.07-1.32) who also had 
higher odds of mortality (OR=1.35, 95% CI: 1.21-1.50) compared to those seen by 
surgeons with 11-20 years since graduation. Similarly, unadjusted odds of complications 
and mortality were higher for patients operated by surgeons with 30 and more years in 
practice (OR=1.24, 95% CI: 1.11-1.39 and OR=1.29, 95% CI: 1.14-1.46 respectively).  
No clear association was found between the outcomes of interest and hospital 
CABG volume. Patients operated at teaching and public hospitals had higher odds of 
complications (OR=1.08, 95% CI: 1.01-1.17 and OR=1.11, 95% CI: 1.02-1.22 
respectively).  
Adjusted Analyses 
Hypothesis 1.1 
Four separate models were fit to examine risk-adjusted mortality and 
complications for on-pump and off-pump CABG. These analyses included only 222 
surgeons performing both types of CABG. The analyses were adjusted for patient 
characteristics, surgeon and hospital characteristics. On-pump, off-pump and total CABG 
volume was expressed as quartiles with the referent category of quartile 4.  
The tables 4-15 and 4-16 present adjusted results for off-pump mortality, off-
pump complications and on-pump mortality and on-pump complications. As Table 4.15 
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demonstrates older age (70-79 referent, and 80 and over OR=1.42, 95% CI: 1.17-1.73), 
emergency admission (OR=1.63, 95% CI: 1.34-1.97), Medicare  insurance (OR=1.37, 
95% CI: 1.05-1.78) and OPCABG operation performed by lower volume surgeon 
(quartile 1 OR=3.05, 95% CI: 1.68-5.53, quartile 2 OR=1.57, 95% CI: 1.10-2.26 and 
quartile 3 OR=1.35, 95% CI: 1.01-1.81) at public (OR=1.51, 95% CI: 1.08-2.11) 
hospitals were significantly associated with higher in-hospital mortality for patients 
undergoing OPCABG. In addition, patients with CHF (OR=2.62, 95% CI: 2.23-3.09), 
pulmonary circulation disease (OR=1.71, 95% CI: 1.16-2.51), valvular disease 
(OR=1.37, 95% CI: 1.13-1.66) and cardiogenic shock (OR=2.14, 95% CI: 1.46-3.13) had 
higher odds of mortality. For complications the following patient risk factors emerged as 
significantly associated with surgical complications: Medicare, Medicaid and other type 
of insurance (OR=1.39, 95% CI: 1.12-1.72, OR=1.83, 95% CI: 1.27-2.63, OR=1.82, 95% 
CI: 1.17-2.85 respectively),  CHF (OR=1.69, 95% CI: 1.45-1.98) and pulmonary 
circulation disease (OR=5.65, 95% CI: 4.32-7.39). In addition, OPCABG surgery 
performed by only quartile 2 physicians retained significance (OR=1.80, 95% CI: 1.29-
2.51) for complications. Other quartiles were not statistically different from the highest-
volume quartile.  
According to Table 4.16 older age (70-79 referent, and 80 and over OR=1.62, 
95% CI: 1.45-1.81), female sex (OR=1.43, 95% CI: 1.31-1.57) emergency or urgent 
admission (OR=1.58, 95% CI: 1.42-1.77 and OR=1.13, 95% CI: 1.01-1.27 respectively), 
Medicare, Medicaid and other type of insurance (OR=1.47, 95% CI: 1.27-1.71, OR=1.71, 
95% CI: 1.31-2.22  and OR=1.49, 95% CI: 1.04-2.13  respectively ) were significantly 
associated with higher in-hospital mortality for patients undergoing CCABG surgery. 
73 
 
CHF, pulmonary circulation disease, Valvular disease, liver disease and cardiogenic 
shock (OR=2.12, 95% CI: 1.93-2.32, OR=1.67, 95% CI: 1.33-2.08,  OR=2.23, 95% CI: 
1.48-3.36  and OR=1.82, 95% CI: 1.44-2.29  respectively ) were also risk factors for 
increased mortality. With respect to surgeon-level predictors CCABG operation 
performed by lower volume surgeons (quartile 2 OR=1.82, 95% CI: 1.34-2.47 and 
quartile 3 OR=1.51, 95% CI: 1.21-1.90) were significantly associated with higher in-
hospital mortality for patients undergoing CCABG surgery. Operations performed by 
quartile 1 surgeons were marginally significant (OR=1.79, 95% CI: 0.99-3.25).   
For CCABG complications, in addition to female sex (OR=1.23, 95% CI: 1.13-
1.33), Medicare insurance (OR=1.24, 95% CI: 1.10-1.39), CHF (OR=1.66, 95% CI: 1.53-
1.81), pulmonary circulation disease (OR=6.17, 95% CI: 5.36-7.10), liver disease 
(OR=1.76, 95% CI: 1.21-2.56) and cardiogenic shock (OR=1.58, 95% CI: 1.27-1.97 ) 
Hispanic ethnicity (OR=1.41, 95% CI: 1.21-1.65) and Black race (OR=1.20, 95% CI: 
1.01-1.44) also emerged as significant patient level-risk factors.  
Surgeries performed by physicians in lower CCABG quartiles were also 
significantly associated with increased odds of complications (quartile 1 OR=1.97, 95% 
CI: 1.19-3.26, quartile 2 OR=1.43, 95% CI: 1.14-1.80 and quartile 3 OR=1.33, 95% CI: 
1.14-1.57).  
Hypothesis 1.2 
Adjusted results presented in Table 4.17 suggest that there was no significant 
association between the lowest surgical total CABG volume (≤ 88 procedures) and 
outcomes measures with OR=1.13, 95% CI: 0.82-1.56 for complications and OR=0.94, 
95% CI: 0.63-1.43 for in-hospital mortality. Only patient risk factors achieved statistical 
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significance for both complications and mortality.  Specifically, female sex (OR=1.21, 
95% CI: 1.13-1.30 for complications and OR=1.34, 95% CI: 1.24-1.44 for mortality), 
Medicare (OR=1.27, 95% CI: 1.15-1.40 for complications and OR=1.44, 95% CI: 1.26-
1.63 for mortality) and Medicaid (OR=1.30, 95% CI: 1.08-1.58 for complications and 
OR=1.66, 95% CI: 1.32-2.08 for mortality) insurance, CHF (OR=1.68, 95% CI: 1.56-
1.81 for complications and OR=2.23, 95% CI: 2.06-2.42 for mortality) pulmonary 
circulation disease (OR=6.02, 95% CI: 5.32-6.82 for complications and OR=1.68, 95% 
CI: 1.39-2.04 for mortality) and cardiogenic shock (OR=1.44, 95% CI: 1.18-1.75 for 
complications and OR=1.90, 95% CI: 1.56-2.31 for mortality) were significantly 
associated with the increased risk for both outcome measures. In addition, mortality-
specific significant risk factors were emergency (OR=1.60, 95% CI: 1.46-1.76) and 
urgent (OR=1.16, 95% CI: 1.05-1.29) admission, while Black race (OR=1.17, 95% CI: 
1.00-1.36) and Hispanic ethnicity (OR=1.20, 95% CI: 1.04-1.38) were significantly 
associated with increased odds of complications.  
Hypothesis 1.3 
As table 4.16 presents, cumulative CABG volume was  not significantly 
associated with surgical outcomes.  
Hypothesis 2.1 
The analyses adjusted for patient characteristics, surgeon board certification and 
experience and hospital ownership and teaching status showed that low surgical volume 
in either high volume or low volume hospitals was not significantly associated with in-
hospital complications and mortality (Table 4.18).  
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Hypothesis 2.2 
As Table 4.19 displays, analyses adjusted for patient risk factors and hospital 
characteristics including bed size, total discharges, total CABG volume (expressed in 
quartiles) and ownership and teaching status did not show any significant association 
between hospital characteristics and adverse outcomes. Only patient-level risk factors 
noted in all other analyses had significant association with the outcomes of interest.  
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CHAPTER 5: DISCUSSION 
 
 
Overall Findings  
This retrospective, cross-sectional study investigated the effect of surgeon volume 
and specialization on patient outcomes after CABG using 2000-2006 Florida hospital 
discharge data.  
Two research objectives and five hypotheses guided this research. First objective 
was to explore the relationship between specific CABG procedures (on-pump and off-
pump), specialty training and in-hospital mortality and complications. Hypothesis H1.1 
under this objective was that higher volume of OPCABG and/or CCABG and specialized 
surgical training (thoracic surgery vs. general surgery) would lead to better outcomes. 
The results supported this hypothesis. For both OPCABG and CCABG lower volume 
was associated with increased odds of complications and mortality. In unadjusted 
analysis, patients operated on by ABS certified surgeons had higher odds of 
complications and mortality. However, this finding did not retain the level of significance 
after adjusting for patient, surgeon and hospital characteristics. These results support the 
findings of other studies which suggest that the surgeon‘s experience and competence 
with performing a specific CABG technique is a key for successful surgery.
147
 This is 
especially true about off-pump CABG which is technically more challenging. According 
to Dr. John Puskas, an associate professor of surgery at Emory University School of 
Medicine in Atlanta, Georgia, ―it takes the most experienced cardiac surgeons between 
1
1
5
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50 and 100 cases before they are very comfortable with the off-pump technique.‖
147
 A 
study, which examined short- and long-term outcomes for 59,044 patients undergoing on-
pump CABG and 9,135 undergoing off-pump CABG between 1997 and 2000 in New 
York State, also suggested that surgeon experience could be a factor in improved 
outcomes.
148
 
Another study hypothesis related to surgeon volume (H1.2) was that the lowest 
volume of CABG procedures would lead to markedly worse outcomes. This hypothesis, 
however, was not supported by the study findings. A systematic review of literature by 
Halm et al
2
 suggested that surgeons with the lowest volume had worse results compared 
with providers in other volume categories. However, the cut-point for this volume 
threshold was much lower (≤1 per year) compared to the cut-point selected for this study 
(≤88 procedures per 7 years). The same research also suggested that formal statistical 
analysis to confirm this finding was often lacking.
2
 
 Hypothesis stating that cumulative surgical volume would be a better indicator 
for improved outcomes (H1.3) was not supported. However, it is important to note that the 
nature and design of this study did not allow to fully evaluate the effect of the different 
measures of volume on outcomes. Total CABG volume (all CABG cases for 7 years of 
data) was already a snapshot of surgical experience as the study design was cross-
sectional. Longitudinal analysis and more detailed information of surgical experience will 
be needed to conduct a complete analysis and test this hypothesis, particularly with 
regard to cumulative volume. This gap has been also noted by other studies, which 
recommend more careful examination whether cumulative surgeon volume occurring 
over many years is a more appropriate volume measure and whether annual surgeon 
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volume is equally important in determining quality of care for surgeons with many years 
of experience versus less experienced surgeons.
149
 
In general, little is known about mechanisms underlying variation in surgeon 
performance
150
 although the role of hospital-procedure and surgeon-procedure volumes 
on CABG outcomes have been investigated by numerous studies to better define whether 
procedure volume effects are surgeon or institutional in origin.
149
 In addition, studies 
have also examined the relationship between surgeon age and adverse surgical outcomes. 
Although surgeon age was not available for the analysis in the present study, information 
on surgeon‘s experience expressed as years in practice may be considered as a proxy for 
age. As seen in the byvariate analysis in the present study, surgeons at two extremes of 
experience (0-10 and 31+ years in practice) had higher mortality rates. This finding is 
supported by Waljee et al who have found that surgeons over 60 years had higher 
mortality rates with pancreatectomy, coronary artery bypass grafting and carotid 
endarterectomy.
150
 One explanation for these results is that older surgeons may have 
diminished fine motor skills, visual acuity and other important competencies, including 
less familiarity with new operative techniques and technologies.
150
 It is important to note, 
however, that in the present study the effect of surgeon experience did not persist after 
controlling for other surgeon and hospital characteristics. It is possible that older 
surgeons make some practice modifications to compensate for the above listed 
disadvantages; for example, they may begin to restrict their practices to less risky 
patients, thus accruing less volume.  
Another important factor related to surgeon experience is the role of 
specialization. Younger surgeons become much more specialized through fellowship and 
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other training opportunities, which may affect the outcomes. So, there may be an 
important modification to ―practice makes perfect‖ hypothesis – there is a new argument 
that not just practice but ―perfect practice makes  ‖.
150
 This trend of targeted 
specialization is particularly noticeable in the field of thoracic surgery, one of the most 
specialized subsets of surgery.
66
 So, for future research it would be useful to evaluate this 
information as well not to rely heavily on surgical volume because volume is endogenous 
to specialization to some extent and it is therefore not possible to fully disentangle its 
effect from the relationship between specialization and outcomes.
20
 
Two hypothesized expectations involving hospital volume were not supported by 
the present study. Hypothesis 2.1 stated that lower volume surgeons in high volume 
hospitals would have a better outcome. Thus, the expectation was that hospital volume 
and some unmeasured institutional factors (more specialized staff, availability of 
advanced technology, etc.) would safeguard low volume surgeons from poor outcomes. 
However, in the light of other studies, the fact that this hypothesis was not supported is 
not surprising. Hospital procedure volume has been found to be only modestly associated 
with CABG outcomes in the study by Peterson et al.45 A very interesting study was 
conducted by Zacharias et al
149
 where they selected a team of high volume surgeons 
serving at two very different centers – one high procedure volume, long-established 
urban hospital meeting the Leapfrog Group volume criteria and the other small, suburban, 
low-volume community hospital. Interestingly, the study demonstrated that when served 
by the same high volume surgeons, similar CABG operative and midterm (3-year) 
outcomes could be achieved in the selected high- and low-volume institutions.
149
  
124 
 
The same study is also relevant to shed light on another hospital-volume related 
hypothesis in the present study. It was postulated that larger hospitals, with more total 
discharges would have better outcomes. The attempt was to measure the effect of some 
institutional attributes that may explain surgical outcomes. Although this hypothesis was 
not supported, it reinforces the notion that more detailed information is needed to address 
this question. In the study conducted by Zacharias et al
149
 two selected hospitals had 
committed substantial resources including dedicated personnel, cardiovascular 
anesthesia, operating rooms, intensive care and step down units. In addition, nursing and 
surgical assistant teams were similarly trained with equivalent operational guidelines.
149
 
Therefore, based on this study, it is not possible to draw any conclusions whether similar 
operative and midterm (3-year) outcomes would have been achievable in the high- and 
low-volume centers had these characteristics been different. These organizational factors 
are critically important in performing a successful surgery. It is particularly true about 
cardiac surgery, which requires a team of experts, participation by a wide array of skilled 
individuals and involvement with complex specialized physical resources.
66
 These 
unmeasured differences may also be contributing to conflicting evidence about the 
importance of hospital volume. For example, Hannan et al
151
 and Wu and colleagues
152
 
reported that high-volume hospitals have lower in-hospital mortality and the benefits 
persist for both low-risk and moderate-to-high-risk CABG.
152
  
One interesting hospital-related finding in the current study is higher odds of 
surgical complications and mortality in the teaching hospitals. Although higher CABG 
volume, as well as best practices for the management of coronary artery disease, such as 
use of angiotensin-converting enzyme inhibitors, aspirin and β-blockers, is more common 
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at teaching hospitals
153, 154
 patients in teaching hospitals did not have lower risk of 
adverse outcomes. This may be due to unmeasured illness severity as it has been reported 
that patients with more disease severity are more likely to seek care at teaching 
hospitals.
155
 Thus, quality of care available at teaching hospitals may be attenuated due to 
incomplete risk adjustment.  
Overall, for all hypotheses the results suggested that patient risks factors are 
strong predictors of CABG outcomes. Patient risk factors associated with in-hospital 
mortality and complications included greater age, female sex, emergency or urgent 
admission, sevaral comorbid conditions and cardiogenic shock.  
Existing research provides strong support for these findings. Studies have found 
that advanced age is the most significant independent correlate of complications and 
death in general
125
 but specifically for CABG, age is also widely recognized as a major 
risk factor for coronary artery disease.
122
 In older patients the response to perioperative 
stress is reduced due to decrease in heart rate and increase in stroke volume for any given 
cardiac output, the volumes of the heart chambers tend to enlarge, for both systole and 
diastole, leading to reduction in left ventricular ejection fraction,
122
 one of the most 
significant predictors of adverse outcomes after CABG surgery.  
Although the influence of gender on the risk of coronary artery disease is 
currently under investigation, it is well-documented that female gender is a risk factor for 
surgical mortality and complications.
125
 Whether this is due to sociologic or physiologic 
factor is currently under intense investigation.
122
   
Similarly, emergency operation has been found to be a major risk factor for 
perioperative mortality and/or prolonged hospital stay regardless of age.
130
 In a study 
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examining thoracic surgery, overall operative mortality was 2.4% rising to 26.4% in 
emergency patients.
130
  
Findings related to the comorbidities in the present study deserve special attention 
and explanation in the context of study limitations arising from the nature of 
administrative data. From as early as 1980s investigators have indicated that  comorbid 
diagnoses are frequently underreported in administrative data, which may bias outcome 
studies.
156-159
 Specifically, in multilevel models in this study hypertension and diabetes 
demonstrate protective effect on in-hospital mortality and complications. These 
surprising findings are replicated and explained by other studies that have also reported 
unexpectedly beneficial effects of diabetes, angina, and other comorbidities on short-term 
mortality using administrative data.
157, 159-161
 Several possible reasons have been 
suggested to explain the phenomenon: coders seem to be underreporting chronic 
conditions as they discard chronic codes to generate truncated fields or they substitute 
acute complications for comorbidities.
157
 In addition, Romano et al
157
 have found that 
sensitivity of comorbidty coding was lowest for hypertension compared to other 
conditions.  It is also conceivable that hypertensive patients are taking some medications 
e.g. β-blockers, calcium channel blockers, nitrates which would be contributing to a 
favorable outcome. In a study with periprocedural myocardial infarction as an end-point 
hypertension was found to be a weak correlate of the outcome.
125
 
Studies have also found no evidence that mild-to-moderate hypertension 
independently increases perioperative risk
122
 so without the ability to distinguish between 
the hypertension class we may be diluting the effect of severe hypertension.   
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In the context of CABG surgery it is also possible to suggest that hypertension 
provides protection from perioperative ischemia, which is one of the frequent adverse 
effects of CABG. This thought is supported by the existing evidence demonstrating that 
reduction of blood pressure intraoperatively was associated with increased risk of 
perioperative ischemia.
122
  
In unadjusted analysis, comorbidities were coded as number of conditions present 
on each discharge record. The odds ratios derived from the analysis confirmed significant 
statistical relationship between the comorbidities and adverse patient outcomes. 
However, of interest was the inverse direction of the association, i.e. patients with higher 
number of comrobid conditions had lower odds of adverse outcomes. The results were 
only ‗typical‘ (i.e. meeting the expectation of higher likelihood of mortality and 
complications with the increased number of comorbid conditions) if four excluded 
variables, described in the study methods section in more detail, other neurological 
disorders, coagulopathy, renal failure, and fluid and electrolyte disorders were included in 
the analysis. This finding warrants additional research to explain how the nature (not the 
number) of comorbid conditions contributes to the risk of adverse outcomes.    
Strengths and Limitations 
The main strength of this study came from using individual surgeon identifiers 
and corresponding information. As noted by other researchers, hospital volume-outcome 
effects are confounded by independent surgeon volume effect.
45, 151, 152
 Thus, it was 
important to separate individual surgeon experience with two different CABG 
techniques. In addition, multilevel modeling utilized for the hierarchical data used for the 
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study allowed to separate the impact of a surgeon‘s skill and the parameters related to the 
hospital staff, systems, and resources.
149
 
Several important study limitations should be noted. As with all research using 
administrative data, the study was unable to examine and control for clinical detail such 
as coronary anatomy, left ventricular systolic function, time on CPB, other clinical 
measures and the severity of the comorbid conditions, which may considerably affect the 
outcomes. Although many studies using clinical data have also shown a significant effect 
of volume on outcome,
2, 46, 162
 these unmeasured differences in patient populations 
operated on by surgeons with different volumes and caseload may result in confounding. 
Moreover, when clinically important information is available in the administrative data 
the lack of important details contributes to the inability to identify subgroups of patients 
at a higher risk. Hannan et al
163
 provide a good example: ICD-9-CM code for "acute 
myocardial infarction (heart attack)," specifies that the heart attack occurred in the 
previous eight weeks. However, patients who had a heart attack within a few hours prior 
to the surgery are at greatly increased risk compared to those suffering the acute 
myocardial infarction (AMI) within a few days prior to the procedure, and it is not 
possible based on administrative data to separate these two groups of patients.
163
 This 
could be an explanation why such an important clinical variable was not statistically 
significant in this study and therefore was not retained in the final models.  
In addition, there is a likelihood that miscodes in the data have occurred, 
especially with regard to extremely low-volume surgeons. It is possible that in some 
discharge records the admitting physician may have been recorded as operating 
physician, which may explain one or two surgeries performed over the seven year study 
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period. Problems in identifying physicians accountable for care have also been reported 
by other studies using administrative data.
164
 However, there is no possibility to 
determine if the procedure is a miscode or actually performed by a surgeon. This creates 
a significant barrier for studying the characteristics and outcomes of extremely low-
volume surgeons. A systematic review of literature has identified that providers with the 
lowest volume had markedly worse results compared to providers in other volume 
categories.
2
 
Some methodological challenges involved in the study should be also noted. As 
previous studies have acknowledged, no validated volume thresholds have been 
established. Moreover, Halm et
2
 al noted that the cut-off points used to define high and 
low volume overlapped substantially among studies: the same number of procedures was 
defined as high volume in one study and low volume in another.
2
 This wide variation in 
the definition of low vs. high volume creates considerable methodological challenges.  
The lack of information on conversion from off-pump to on-pump CABG and 
corresponding lack of adjustment for conversion is also a limitation. It has been reported 
that those who converted to CPB intraoperately had higher mortality rates (converters 
3.47% [95% CI 3.16%-3.77%] vs. nonconverters 2.53% [95% CI 2.46%-2.61%]).
165
  
In addition, the analysis accounts for only a limited number of organizational 
factors, which are often likely to contribute to improved surgical outcomes 
(multidisciplinary team, staffing ratios, availability of technology and specialized 
equipment including specialized intensive care units and operating rooms, preoperative 
risk assessments and recommendations by other physicians, etc).  
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Due to the nature of administrative data the distinction between hospital-acquired 
problems and prehospitalization problems was hard to make.
166
 The data used for the 
analysis did not contain a ―present on admission‖ (POA) indicator, which was 
legislatively mandated to be added to administrative claims data in 2007.
97
 However, 
eight PSIs used in this study (PSI 5, PSI 6, PSI 7, PSI 9, PSI 10, PSI 11, PSI 13, and PSI 
15) have been found to remain potential patient safety problems after eliminating 
conditions reported as POA.
97, 98
  The only patient safety indicator used for the analysis 
with less likelihood to be still considered a potential patient safety problem after 
eliminating conditions reported as POA is PSI 12 - postoperative pulmonary embolism or 
deep vein thrombosis.
97
 Thus, PSIs selected for the analysis in this study are adequate 
measures of in-hospital complications.   
Similarly, as noted in the example of AMI the lack of clinical details contributes 
to the inability to distinguish between risk factors and complications. For example, if 
intra-aortic balloon pump is inserted prior to the CABG surgery it would be a risk factor 
arising from the problems present at admission to the hospital but if it was inserted and 
necessitated by the CABG surgery it would suggest surgical complication.
163
  
In addition, the well-accepted outcome measures used in this study may no longer 
capture the differences at a deeper level. For example, one of the study outcomes – 
mortality is argued to most reflect technical skills but not necessarily familiarity with and 
use of contemporary medical knowledge.
150
 Moreover, the processes of care in general 
have been standardized and advances in CABG surgery have been universally adopted so 
measuring in-hospital mortality may no longer be able to capture subtle differences in 
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quality of care. Some surgeons argue that the ability to rescue most patients who have a 
complication and keep most everyone alive confounds the mortality statistics.
150
  
Finally, the study used data from one state and therefore findings may not be 
generalizable to other states especially those without certificate of need (CON), which 
most likely is affecting the distribution of CABG surgery among Florida hospitals.  
Policy and Practice Implications 
This study has suggested that performance of a specific type of CABG (CCABG 
vs. OPCABG) is associated with better outcomes. This finding may suggest the need of 
specialized and focused training of cardiac surgeons as well as specific CABG outcomes 
reporting protocols so that there is sufficient differentiation in outcomes of two different 
types of CABG. So far, OPCABG has received minimal attention with respect to 
outcome evaluation and reporting.  
Future directions for CABG research should be focused on collecting richer data 
with more clinical information to address the concerns about important contributing 
factors for improved patient outcomes. Some quite specific recommendations can be 
made to fill the gap: 1) it should be possible to introduce coding of off-pump to on-pump 
conversion in the administrative data. This information alone would substantially inform 
the CABG research and practice; 2) clear and validated CABG volume thresholds should 
be established not only for hospitals but more importantly for surgeons; 3) information on 
surgical training (residency, fellowship, type of medical program) should be systematized 
and made available to researchers to fully evaluate the effect of training and 
specialization on surgical outcomes.  
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Like many other studies, present analysis emphasized the importance of rigorous 
risk adjustments, which is a complex construct involving patient's socio-demographic 
factors (e.g. age, gender, race/ethnicity), clinical stability, severity of primary disease, 
functional status, and burden of comorbidity.
167
 Many methods have been developed to 
measure and control comorbidities, the Elixhauser comorbidity measure being one of the 
most commonly used instruments for risk adjustment. However, findings of many 
studies, with the current one included, suggest the need of revalidation of the measures, 
perhaps specifically for some major procedures/primary disease. In addition, incomplete 
or incorrect coding in administrative data should be reduced, if not eliminated, as a 
source of bias for risk models and hospitals should be encouraged to address the issue of 
selective underreporting and therefore improve reporting of coexisting conditions on 
discharge abstracts and claims.
168
 
This study should be viewed in the light of the current historical events related to 
health care reform. Affordable Care Act of 2010 (ACA) is expected to change the face of 
medicine in the United States. With expanded health coverage for over 30 million 
individuals, insurance reforms, potential implementation of different models for delivery 
of health services, the ACA is going to fundamentally change nearly every aspect of the 
US health care. These major changes offer both challenges and opportunities. The 
opportunity is long awaited - to improve health care for vulnerable populations, reduce 
racial and ethnic disparities in health, and practice medicine without worrying about 
whether patients will be able to pay for needed care.
169
 However, to achieve this several 
important challenges will need to be addressed. Superb medical/surgical education and 
training of competent, and  sufficient workforce, which has made the US system the best 
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in the world, needs to be sustained and optimized.
170
 The ACA has no provisions to 
ensure adequate workforce training and retention. Attention is only given to creating 
incentives for primary care to address the declining number of physicians in this field. 
This may create an additional challenge for many specialty areas including thoracic 
surgery. Physician extenders who have compensated for the deficit of primary care 
physicians cannot play the same role for surgical specialties – they cannot operate.
170
The 
problem of workforce shortage is further exacerbated by the fact that the funding for 
resident training comes from Medicare – each accredited training program receives 
approximately $100,000 per trainee per year, around $9.5 billion a year spent by the 
federal government.
170
 So, potential reduction in these funds, which will not be 
noticeable for public as it happens, will most likely have a major negative impact on 
resident education, number of residents being trained, as well as on hospital budgets.
170
  
Although not directly evaluated by the current study, the impact of age on surgical 
workforce is important. Advanced age of surgeons may contribute to adverse patient 
outcomes or workforce shortage as they retire. Currently, thirty-five percent of the 
surgical workforce is over 55 years, by 2014 that number is predicted to be 42 percent.
170
 
These implications need to be seriously considered by the government and policy makers 
to ensure sustainable quality care, handle the increased workload, including CABG 
surgeries and balance supply and demand.  
Physician-hospital alignment is likely to change as a result of new law. A ―work-
shop‖ model, also seen in this study, where surgeons operate on patients in multiple 
hospitals may no longer exist as payment reforms (e.g., bundled payments, performance-
based incentives) and legal compliance obligations impose increased financial and legal 
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liability burden on physician practice. This will likely lead to an increase in 
administrative costs for required infrastructure and quality measurement and will compel 
physicians to consolidate with other practitioners, become hospital employees, or align 
with large entities and health systems for capital, administrative and technical 
resources.
171
 Such alignment is expected to better handle the shift of the risk, or 
"accountability," for care from insurers to providers. Some, however, speculate that 
physicians will decide to exit to administrative roles in hospitals or leave practices 
alltogether,
171
 which will further exacerbate workforce shortage discussed above. 
The present study has found that low-volume surgeons provide care to higher 
proportion of vulnerable populations. With more than 30 million previously uninsured 
individuals added to the patient load two things can happen: (1) volumes of surgeons may 
increase across the board for all volume categories, (2) workload of low volume surgeons 
may increase substantially which can contribute to improved surgical outcomes through 
the mechanism of ―practice makes perfect‖. In general, we may see a reversal of the 
CABG trends described previously – after more than 10 years of steady decline CABG 
rates may go up. This expectation is based on the perception that population, which was 
uninsured for years and therefore could not access costly cardiac care, may have severe 
CAD, presumably going untreated for a long time, which would require surgical 
intervention.  
Provided that access to health care challenges are addressed, quality of care is 
likely to benefit from the changes imposed by the ACA. The law includes provisions that 
reward quality/efficiency performance such as shared savings contracts with Accountable 
Care Organizations (ACO), and reporting and tracking system for improved quality 
135 
 
metrics. Incentive payments for physicians voluntarily participating in Medicare‘s 
Physician Quality Reporting Initiative (PQRI) and in Maintenance of Certification 
Program are provided under the law. In addition, starting from 2015, physicians will be 
penalized 1.5 percent of Medicare payment and 2.0 percent of payment in following 
years if they do not successfully participate in the PQRI.
171
 This may be the best time for 
health services researchers and policy makers to help improve reporting protocols and 
thereby generate richer and improved data with robust measurement capabilities. The 
need for such improvement has been once again emphasized in the current study as it 
related to risk-adjustment and provider profiling. The latter has even greater potential  for 
improvement as Department of Health and Human Services plans to create a web site 
showing quality metrics on physicians. Physician Compare website will contain 
information on physicians participating in the PQRI program. It is also required to make 
information on physician performance publicly available by 2013. As discussed above, 
this information needs to include details on physician training and practice.  
Taken together, the implications of the ACA for policy practice and health care 
delivery is enormous although as White Paper Examining the Effects of The Patient 
Protection and Affordable Care Act on Physician Practices in the United States puts it, 
―direction apparent, details pending‖.
172
 It is clear that changes imposed by the healthcare 
reform law are substantial and will be phased in over many years to come. The 
implications related to the current study as outlined above undoubtedly are  just few 
among multiple that will influence the cardiac care.  
In concusion, this study has the advantage of being comprehensive (with more 
than 119,59 patients) and population-based (including all patients undergoing CABG 
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procedures in the State of Florida hospitals between 2000 and 2006). Beneficial effect of 
high volume of CABG found in this study supports existing evidence on the protective 
effect of procedure volume but takes one more step further suggesting that procedure-
specific, i.e. proportional volume is more important in determining improved surgical 
outcomes.  
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APPENDIX A: PUBLICLY AVAILABLE INFORMATION ON SURGICAL 
VOLUME 
 
 
Name of Source  Sponsor  Area Represented  Source of data  
Health Grades Proprietary United States National Medicare 
database 
Leapfrog Group Business roundtable United States  Self-reported by 
hospital 
Hospital Quality 
Reports 
BlueCross 
BlueShield 
Upstate New York State hospital 
discharge database 
Indicators of 
Inpatient Care in 
Texas Hospitals, 
2000 
 
Texas Health Care 
Information Council 
 
Texas  
 
State hospital 
discharge database 
 
Pennsylvania 
Hospital 
Performance 
 
Pennsylvania Health 
Care 
 
Pennsylvania  State hospital 
discharge database 
 
Reports Cost Containment 
Council 
  
 
Source: Dimick et al. World J. Surg. Vol. 29, No. 10, October 2005.
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